<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC5834428</article-id><article-id pub-id-type="pmcid-ver">PMC5834428.1</article-id><article-id pub-id-type="pmcaid">5834428</article-id><article-id pub-id-type="pmcaiid">5834428</article-id><article-id pub-id-type="pmid">29535724</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.00348</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>T Cell Subsets in the Germinal Center: Lessons from the Macaque Model</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vaccari</surname><given-names initials="M">Monica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://frontiersin.org/people/u/469748"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Franchini</surname><given-names initials="G">Genoveffa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Animal Models and Vaccine Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute</institution>, <addr-line>Bethesda, MD</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Vijayakumar Velu, Emory University, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Matthieu Perreau, Centre Hospitalier Universitaire Vaudois (CHUV), Switzerland; Huanbin Xu, Tulane University, United States; Elizabeth Connick, University of Arizona, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Monica Vaccari, <email>vaccarim@mail.nih.gov</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to HIV and AIDS, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><issue-id pub-id-type="pmc-issue-id">305241</issue-id><elocation-id>348</elocation-id><history><date date-type="received"><day>31</day><month>10</month><year>2017</year></date><date date-type="accepted"><day>07</day><month>2</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>13</day><month>03</month><year>2018</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2018-03-28 00:56:05.747"><day>28</day><month>03</month><year>2018</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2018 Vaccari and Franchini.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Vaccari and Franchini</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-09-00348.pdf"/><abstract><p>Germinal centers (GCs) are organized lymphoid tissue microstructures where B cells proliferate and differentiate into memory B cells and plasma cells. A few distinctive subsets of highly specialized T cells gain access to the GCs by expressing the B cell zone&#8211;homing C-X-C chemokine receptor type 5 (CXCR5) while losing the T cell zone&#8211;homing chemokine receptor CCR7. Help from T cells is critical to induce B cell proliferation and somatic hyper mutation and to limit GC reactions. CD4<sup>+</sup> T follicular helper (T<sub>FH</sub>) cells required for the formation of GCs and for the generation of long-lived, high-affinity B cells. Regulatory CD4<sup>+</sup> (T<sub>FR</sub>) and CD8<sup>+</sup> T cells co-localize with T<sub>FH</sub> cells and keep their expansion in check, thus limiting GC reactions. A cytotoxic CXCR5<sup>pos</sup> CD8<sup>+</sup> T cell subset has been described in GCs in humans: although low in number, GC CD8<sup>+</sup> T cells can expand rapidly during certain viral infections. Because these subsets find their home in secondary lymphoid tissues (lymph nodes and spleen) that are difficult to obtain in humans, GC&#8211;homing T cells have been extensively studied in mice. Nevertheless, significant limitations in using this model, such as evolutionary divergences between mice and humans and the lack of an optimal mouse model for certain human diseases, have prompted investigators to characterize GC&#8211;homing T cells in macaques instead. This review will focus on discoveries made in macaques, particularly in the non-human primate models of simian immunodeficiency virus and simian&#8211;human immunodeficiency virus infection. Indeed, experimental studies in these models have allowed researchers to gain insight into the relative role of follicular T cell subsets in HIV progression, virus persistence, and specific B cell responses induced by HIV vaccines. These discoveries have prompted the testing of novel approaches aimed to manipulate follicular T cells to increase the efficacy of HIV vaccines and to eliminate HIV reservoirs.</p></abstract><kwd-group><kwd>T follicular helper cell</kwd><kwd>T follicular regulatory cells</kwd><kwd>non-human primate</kwd><kwd>HIV infections</kwd><kwd>simian immunodeficiency virus</kwd><kwd>germinal center</kwd></kwd-group><counts><fig-count count="0"/><table-count count="2"/><equation-count count="0"/><ref-count count="121"/><page-count count="11"/><word-count count="10629"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Effective antibody responses are crucial for preventing viral infections and are the basis for the majority of successful vaccination strategies (<xref rid="B1" ref-type="bibr">1</xref>). The quality of such antibodies is largely dependent on T cell&#8211;B cell interactions. In physiological conditions, T and B cells are subcompartmentalized within lymphoid lobules of lymph nodes (LNs). B cells reside within the outer cortex areas of the lobules enriched for the B cell-attracting CXCL13, while T cells express the (C-C motif) receptor 7 (CCR7) and recirculate through the paracortex and interfollicular cortex enriched in CCR7 ligands (CCL21 and CCL19). Following antigenic stimulation, a small number of activated T cells lose CCR7 expression and upregulate CXCR5, the receptor for CXCL13 (<xref rid="B2" ref-type="bibr">2</xref>&#8211;<xref rid="B4" ref-type="bibr">4</xref>). CXCR5<sup>pos</sup> T cells travel toward the B cell-rich follicles in the outer cortex areas, where they interact with B cells (<xref rid="B5" ref-type="bibr">5</xref>&#8211;<xref rid="B7" ref-type="bibr">7</xref>). Two highly specialized CXCR5<sup>pos</sup> CD4<sup>+</sup> T cell subsets, T follicular helper (T<sub>FH</sub>) and T regulatory (T<sub>FR</sub>) cells, have been identified in B cell follicles. Activated T<sub>FH</sub> cells migrate to the T&#8211;B borders and B cell follicles where they are required for the formation and maintenance of germinal centers (GCs) [reviewed in Ref. (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>)]. GCs are organized lymphoid tissue microstructures where B cells expand and differentiate during immune responses to appropriate pathogens or antigens (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>). In the GCs, T<sub>FH</sub> cells support B cells class switching recombination and somatic hypermutation (SHM) (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>). GC reactions ultimately result in the selection of resting B cell memory cells and long-lived plasma cells producing antibodies with high affinity for the encountered antigen (<xref rid="B13" ref-type="bibr">13</xref>). The strong reaction occurring in the GCs needs to be tightly regulated to avoid the generation of autoantibodies and excessive inflammation (<xref rid="B14" ref-type="bibr">14</xref>&#8211;<xref rid="B17" ref-type="bibr">17</xref>). T follicular regulatory cells have recently been described as a subset of CXCR5<sup>pos</sup> T regulatory cells that co-localize with T<sub>FH</sub> cells, control their expansion, and modulate T<sub>FH</sub> cell-driven B cell maturation, antibody class switching, and affinity maturation (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). CD8<sup>+</sup> T cells are also part of the follicular T cell population (<xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B25" ref-type="bibr">25</xref>). Recent studies have started to shed light on the role of these cells in regulating GC reactions and their interaction with T<sub>FH</sub> and B cells in certain infections (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>&#8211;<xref rid="B25" ref-type="bibr">25</xref>).</p><p>Because of their critical role in every step of B cell differentiation, T<sub>FH</sub> cells have been the focus of intense interest in HIV infection. Indeed, aberrant B cell responses and B cell dysfunction are characteristics of chronic HIV infection (<xref rid="B26" ref-type="bibr">26</xref>). T<sub>FH</sub> cells are infected with HIV (<xref rid="B27" ref-type="bibr">27</xref>&#8211;<xref rid="B29" ref-type="bibr">29</xref>), they accumulate in lymphoid tissues of some individuals during chronic infection (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>), and their ability to provide B cell help is impaired (<xref rid="B30" ref-type="bibr">30</xref>). Hence, HIV-associated changes in T<sub>FH</sub> cells most likely affect the generation of effective B cell responses against the virus. Moreover, by homing to the GCs, T<sub>FH</sub> cells escape immunological control and establish a persistent reservoir (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The quest for an effective vaccine against HIV has also fueled intense interest in the biology of CXCR5<sup>pos</sup> T cells and their role in GC reactions. Ideally, an HIV vaccine would induce high affinity broadly neutralizing HIV-1 antibodies capable of neutralizing multiple HIV-1 viral strains. These antibodies show remarkable levels of somatic mutation (<xref rid="B32" ref-type="bibr">32</xref>); henceforth, their generation is most likely highly dependent on effective T<sub>FH</sub>&#8211;B cell interactions in GCs.</p><p>Much of the current knowledge on the role of GC-resident T cells during HIV infection has been attained by studies performed in non-human primate (NHP) models. Macaques can be infected with the simian immunodeficiency virus (SIV) that closely mimics many aspects of HIV infection (<xref rid="B33" ref-type="bibr">33</xref>), giving the NHP model advantages by comparison to both rodents and humans. This review will focus on discoveries made in macaques, on how GC&#8211;homing T cells are affected during HIV/SIV infection, and on how HIV-associated changes in these cells may alter antibody responses. Strategies tested in NHP models aimed to target T<sub>FH</sub> cells to eliminate HIV reservoir from GCs and to increase the effectiveness of HIV vaccine responses will also be discussed.</p><sec id="S1-1"><title>Characterization of GCs in NHPs</title><p>Studies in mice have been fundamental in revealing the phenotype and function of GC-resident T cells and studying their key lineage-specific transcription factors (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B34" ref-type="bibr">34</xref>). However, the similarity between humans and NHPs makes NHPs optimal for research on complex immunological interactions. Macaques have several advantages over rodents, and the first is that their genetic evolution more closely resembles those of humans (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). For example, evolutionary divergence between the signaling pathways that shape T<sub>FH</sub> cell differentiation in humans and mice has recently been discovered (<xref rid="B37" ref-type="bibr">37</xref>). Second, their immune system also resembles those of humans. Indeed, NHPs have been used to study fundamental aspects of immunology, including the development and maintenance of T cell memory (<xref rid="B38" ref-type="bibr">38</xref>), immunodominance (<xref rid="B39" ref-type="bibr">39</xref>), and the aging immune system (<xref rid="B40" ref-type="bibr">40</xref>). Third, macaques LN&#8217;s structure is more similar to humans than rodents LN&#8217; structure (<xref rid="B41" ref-type="bibr">41</xref>). In macaque lobes, T cell zones and B cell follicles can be identified with equal function and cell distribution as in humans. Finally, lymphoid cells and a number of their different subtypes are also identifiable with equivalent markers and methodologies used in humans.</p><p>Germinal centers are typically few in LNs of naive animals, with very little T<sub>FH</sub> cell number (<xref rid="B31" ref-type="bibr">31</xref>). Upon vaccination or infection, selected follicles are activated and develop into GCs. The interactions between cognate B and T cells have been reported to occur 1&#8211;2&#8201;days after antigen exposure (<xref rid="B42" ref-type="bibr">42</xref>&#8211;<xref rid="B44" ref-type="bibr">44</xref>). Studies in macaques have shown that GCs are formed in draining LNs a few days after intramuscular immunization at the same site of the delivery, while they are absent in contralateral LNs (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). GCs in macaques can be readily identified as positive for the B cell marker CD20 and express high levels of the proliferation marker Ki67 (CD20<sup>pos</sup> Ki67<sup>hi</sup>). Alternatively, Hoechst staining of nuclei is used to discern GCs from the adjacent marginal zone by less intense staining in immunohistochemistry analyses (<xref rid="B47" ref-type="bibr">47</xref>). Marginal zone B cells, responsible for an early antibody response to blood-borne pathogens, have been identified in cynomolgus and rhesus monkeys as B cells (CD19<sup>+</sup>, CD20<sup>+</sup>) expressing high levels of complement receptor 2 (CD21) and low levels of CD27 (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). CD4, CD20, PD-1, and Ki67 markers were simultaneously used to study B follicles and T<sub>FH</sub> cells in rhesus macaques (<xref rid="B48" ref-type="bibr">48</xref>).</p><p>Compared to human subjects, the use of NHPs allows researchers to conduct controlled challenge experiments, multiple live surgeries, and invasive and terminal experiments, ultimately granting access to different tissues to an extent that is not feasible in humans (<xref rid="B49" ref-type="bibr">49</xref>). NHP models have also been used to test sampling techniques aimed to study the cellular composition of GCs. While in macaques it is possible to surgically remove the draining LNs at different time points after an immunization or an experimental infection, this procedure is invasive and may disrupt ongoing immune responses. Two studies have used fine-needle aspirations (FNAs) technique to collect cells from LNs of pigtail and rhesus macaques (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B51" ref-type="bibr">51</xref>). In both models, T<sub>FH</sub> cell where readably measurable, suggesting that FNA may be an interesting alternative to collect small numbers of GC cells for further analyses, while maintaining ongoing immune responses.</p></sec><sec id="S1-2"><title>Characterization of T<sub>FH</sub> Cells in Macaques</title><p>T<sub>FH</sub> cells in macaques have a phenotype comparable to that of humans. T<sub>FH</sub> cells are considered a distinct cell subset with a specialized function and a specific transcription factor that differs from other T helper cell subsets. The master regulator of T<sub>FH</sub> cell differentiation is the transcription factor Bcl-6 (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). While Bcl-6 is the unique marker of T<sub>FH</sub> cells, other canonical markers used to identify them are CXCR5, PD-1, and the inducible T cell costimulator, ICOS. High expression of PD-1 has been considered an effective way to identify GC&#8211;T<sub>FH</sub> cells in intact tissues (<xref rid="B31" ref-type="bibr">31</xref>) when GCs are co-stained. In healthy macaques, PD-1<sup>hi</sup> cells within the GCs are almost exclusively CD4<sup>+</sup> T cells (<xref rid="B31" ref-type="bibr">31</xref>). Different combinations of markers have been used to define T<sub>FH</sub> cell in cell suspensions by flow cytometry, in human and macaques (Table <xref ref-type="table" rid="T1">1</xref>). The percentage of T<sub>FH</sub> cells frequency in LNs depends on the choice of the markers used to define and the gating strategy. Because of the unavailability of a cross-reactive antibody for CXCR5, T<sub>FH</sub> cells were originally identified in secondary lymphoid tissues of pigtail macaques as CD4<sup>+</sup> T cells-expressing programmed cell death 1 of PD-1<sup>hi</sup> and low levels of interleukin-7 receptor alpha (IL-7R&#945;) chain (CD127) (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B54" ref-type="bibr">54</xref>). This cell population was only present in spleen and LNs, but not in blood, and expressed high levels of ICOS and Bcl-6. In rhesus macaques, T<sub>FH</sub> cells were first identified in cell suspension from LNs as central memory (CD28<sup>hi</sup> CD95<sup>hi</sup>) CD4<sup>+</sup> T cells expressing low levels of CCR7<sup>lo</sup> and high levels of PD-1 and ICOS (<xref rid="B55" ref-type="bibr">55</xref>). When the cross-reactive anti-CXCR5 antibody clone MU5UBEE became available, co-expression of CXCR5, coupled with high levels of PD-1 expression, has been widely used to identify and sort T<sub>FH</sub> cells (<xref rid="B56" ref-type="bibr">56</xref>&#8211;<xref rid="B59" ref-type="bibr">59</xref>). However, others have reported changes in both markers, and particularly in PD-1 following <italic toggle="yes">ex vivo</italic> HIV infection, warning against using only these two markers to define T<sub>FH</sub> cells (<xref rid="B60" ref-type="bibr">60</xref>).</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Markers to define TFH cells in cell suspension in humans and macaques.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Species</th><th valign="top" align="left" rowspan="1" colspan="1">Tissue</th><th valign="top" align="left" rowspan="1" colspan="1">Infection/treatment</th><th valign="top" align="left" rowspan="1" colspan="1">TFH definition</th><th valign="top" align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac251</td><td align="left" valign="top" rowspan="1" colspan="1">CD28<sup>hi</sup> CD95<sup>hi</sup> CCR7<sup>low</sup> PD-1<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B55" ref-type="bibr">55</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pigtail macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN, spleen</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac239/SIVmac251</td><td align="left" valign="top" rowspan="1" colspan="1">CD8<sup>&#8722;</sup> CD45RA<sup>&#8722;</sup> PD-1<sup>hi</sup> CD127<sup>low</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B54" ref-type="bibr">54</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac239</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B31" ref-type="bibr">31</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian and Chinese rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN, spleen</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac251</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B61" ref-type="bibr">61</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac251</td><td align="left" valign="top" rowspan="1" colspan="1">CD95<sup>+</sup> FOXP3<sup>&#8722;</sup> CXCR5<sup>+</sup> PD-1<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B57" ref-type="bibr">57</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVsmE660</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>hi</sup> FOXP3<sup>&#8722;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B58" ref-type="bibr">58</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac251, SHIV</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B62" ref-type="bibr">62</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="center" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">PD-1<sup>hi</sup> (enriched TFH)</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B56" ref-type="bibr">56</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B28" ref-type="bibr">28</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+, HIV&#8201;+&#8201;ART, and LTNP</td><td align="left" valign="top" rowspan="1" colspan="1">CD45RA<sup>&#8722;</sup> CXCR5<sup>+</sup> PD-1<sup>+</sup> BCl-6<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B27" ref-type="bibr">27</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">Spleen</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CD45RA<sup>&#8722;</sup> CCR7<sup>&#8722;</sup> CXCR5<sup>+</sup> PD-1<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B29" ref-type="bibr">29</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CD45RA<sup>&#8722;</sup> CXCR5<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B30" ref-type="bibr">30</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">Blood</td><td align="center" valign="top" rowspan="1" colspan="1">&#8211;</td><td align="left" valign="top" rowspan="1" colspan="1">CD45RA<sup>&#8722;</sup> CXCR5<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B63" ref-type="bibr">63</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">Blood</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> CXCR3<sup>&#8722;</sup> PD-1<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B64" ref-type="bibr">64</xref>)</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">ART, antiretroviral treatment; LN, lymph node; SHIV, simian&#8211;human immunodeficiency virus; SIV, simian immunodeficiency virus; TFH, T follicular helper cell</italic>.</p></table-wrap-foot></table-wrap><p>Macaques have been a useful model for validating circulating biomarkers of GC responses that can be easily translated to humans. One example is the measurement of the level of plasma CXCL13. In macaques, CXCL13 is detectable in plasma, it increases following immunization, and its levels are associated with the frequency of T<sub>FH</sub> cells in LNs (<xref rid="B65" ref-type="bibr">65</xref>). Importantly, a substantial frequency of CD4<sup>+</sup> T cells expressing CXCR5 is also present in the blood of rhesus macaques, as is the case in humans (<xref rid="B63" ref-type="bibr">63</xref>). Phenotypically, circulating T<sub>FH</sub> (cT<sub>FH</sub>) cells share common markers with GC-resident T<sub>FH</sub> cells and can be identified as CXCR5<sup>pos</sup> PD-1<sup>pos</sup> CD4<sup>+</sup> T cells. However, cT<sub>FH</sub> cells express lower levels of ICOS and of the activation marker CD69 than GC T<sub>FH</sub> cells, suggesting that they are present in a resting phase (<xref rid="B66" ref-type="bibr">66</xref>). While the origin of cT<sub>FH</sub> cells is still unclear, the marker expression and ability to interact with B cells and promote B cell responses <italic toggle="yes">in vitro</italic> suggest that they may be circulating counterparts of T<sub>FH</sub> cells in LNs. In mice, humans, and macaques, circulating CXCR5<sup>pos</sup> PD-1<sup>hi</sup> CD4<sup>+</sup> T cells are heterogenic and can be divided into subsets based on their expression on (C-X-C motif) chemokine receptor 3 (CXCR3), a marker for CD4<sup>+</sup> T helper type 1 (Th1) cells, alone or together with CCR6. CXCR5<sup>pos</sup> CXCR3<sup>neg</sup> PD-1<sup>pos</sup> T<sub>FH</sub> cells present the most genetic and functional similarities to T<sub>FH</sub> cells in LNs (<xref rid="B64" ref-type="bibr">64</xref>). When the expression of CCR6 is considered, cT<sub>FH</sub> cells can be further divided into three subpopulations that mirror the unique phenotype and cytokine signature of lineages of non-T<sub>FH</sub> CD4<sup>+</sup> T cells in blood: T<sub>FH</sub> type 1 (CXCR3<sup>pos</sup> CCR6<sup>neg</sup>), type 2 (CXCR3<sup>neg</sup> CCR6<sup>neg</sup>), and type 17 (CXCR3<sup>neg</sup> CCR6<sup>pos</sup>). More studies are needed to identify the role of these cell subsets in generating or maintaining antibody responses to pathogens.</p><p>Functionally, T<sub>FH</sub> cells help B cells by secreting cytokines and expressing surface molecules and providing survival, proliferation, and differentiation signals [reviewed in Ref. (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B67" ref-type="bibr">67</xref>).]. In macaques, as in humans, GC-resident T<sub>FH</sub> cells express the costimulatory receptor ICOS, the costimulatory protein CD40L required for B cell survival, and they produce the B cell helper cytokines IL-21 and IL-4 although T<sub>FH</sub> cells can also produce other cytokines depending on the stimulus they receive (<xref rid="B9" ref-type="bibr">9</xref>). IL-21 signaling is pivotal for B cell differentiation and for the development of B cell memory. <italic toggle="yes">In vitro</italic> IL-21 production is often used as a means to measure antigen-specific responses, particularly following immunization in humans (<xref rid="B68" ref-type="bibr">68</xref>) and macaques (<xref rid="B69" ref-type="bibr">69</xref>). However, T<sub>FH</sub> and cT<sub>FH</sub> cells produce limited quantities of IL-21. As a result, the tracking of antigen-specific responses by intracellular staining is challenging. A recent study has used the macaque model to develop a cytokine-independent technique aimed improve the quantification of antigen-specific T<sub>FH</sub> cells. Havenar-Daughton et al. have shown that the co-expression of OX40 and CD25 surface markers is sufficient to identify antigen-specific GC T<sub>FH</sub> and pT<sub>FH</sub> cells in the LNs and blood of immunized animals (<xref rid="B70" ref-type="bibr">70</xref>). Importantly, this technique offers the possibility to isolate antigen-specific T<sub>FH</sub> cells by cell sorting, which is not possible with intracellular cytokine detection.</p></sec><sec id="S1-3"><title>HIV-/SIV-Associated Changes in T<sub>FH</sub> Cells</title><p>HIV infection is associated with numerous B cell anomalies (<xref rid="B26" ref-type="bibr">26</xref>). Untreated HIV and AIDS patients develop profound B cell dysfunction, characterized by hypergammaglobulinemia, and polyclonal B cell activation (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B71" ref-type="bibr">71</xref>&#8211;<xref rid="B73" ref-type="bibr">73</xref>). The majority of HIV-infected individuals and SIV-infected macaques fail to produce protective antibodies against HIV/SIV and low-affinity B cells mature inappropriately into plasma cells (<xref rid="B74" ref-type="bibr">74</xref>). Because T<sub>FH</sub> cells are required for the induction of high-affinity antibody responses and the generation of long-lived B cell memory (<xref rid="B75" ref-type="bibr">75</xref>), several groups have investigated HIV/SIV-associated changes in T<sub>FH</sub> cells and their possible effect on B cell abnormalities.</p><p>Recent data suggest that GC&#8211;CXCR5<sup>+</sup> PD-1<sup>hi</sup> T<sub>FH</sub> cells are susceptible to HIV-1/SIV infection (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Interestingly, unlike non-T<sub>FH</sub> CD4<sup>+</sup> T cells, T<sub>FH</sub> cell frequency and number increase in chronic HIV/SIV infection in the LNs of some humans (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>) and macaques (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B60" ref-type="bibr">60</xref>). In both macaques and humans, the increase in T<sub>FH</sub> cell frequency in chronic infection is approximately 10 times compared to non-infected levels (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B55" ref-type="bibr">55</xref>). In humans, a median of 60% of HIV-1 RNA-producing cells was found within lymphoid follicles by <italic toggle="yes">in situ</italic> hybridization in chronically infected untreated patients with a median of 17% of follicles tissues per inguinal LN (<xref rid="B22" ref-type="bibr">22</xref>).</p><p>Remarkably, in all the studies reported, T<sub>FH</sub> cell expansion is observed only during chronic infection, but not in acute infection. Although the reason for the increase in T<sub>FH</sub> cell levels during chronic HIV/SIV infection is not clear, different hypotheses have been proposed. The accumulation of T<sub>FH</sub> cells during chronic SIV and HIV has been associated with immune activation (<xref rid="B55" ref-type="bibr">55</xref>) and plasma viremia (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>) in some studies. Other studies suggest that this expansion may be driven by prolonged T cell receptor stimulation (<xref rid="B62" ref-type="bibr">62</xref>). In mice, LCMV infection redirects CD4<sup>+</sup> T cell development away from the Th1&#8201;cell responses induced during an acute infection toward T<sub>FH</sub> cells (<xref rid="B76" ref-type="bibr">76</xref>). Others have shown that HIV-specific GC&#8211;T<sub>FH</sub> cells, particularly against the gag, also expanded in chronic infection in humans (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Finally, effective antiretroviral treatment (ART) decreases the number of T<sub>FH</sub> cells in humans and macaques, suggesting that active HIV replication is necessary for T<sub>FH</sub> cell expansion (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>).</p><p>The increase in T<sub>FH</sub> cells levels is also associated with increased frequency of activated GC B cells and SIV-specific antibodies (<xref rid="B55" ref-type="bibr">55</xref>) in macaques, and plasma cells and immunoglobulin levels in HIV infection (<xref rid="B28" ref-type="bibr">28</xref>). Moreover, broadly neutralizing antibodies (bNabs) are present in HIV patients with high levels of circulating CXCR5<sup>pos</sup> CXCR3<sup>neg</sup> PD-1<sup>hi</sup> CD4<sup>+</sup> T cells (<xref rid="B64" ref-type="bibr">64</xref>). These results suggest that T<sub>FH</sub> cells may be highly functional during HIV/SIV infection; however, other studies have revealed that they provide inadequate help to B cells (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B77" ref-type="bibr">77</xref>). GC-resident T<sub>FH</sub> cells isolated from HIV-infected patients produce less IL-21, a cytokine pivotal for GC formation, GC B cell proliferation, and B cell maturation (<xref rid="B9" ref-type="bibr">9</xref>). The replenishment of exogenous IL-21 <italic toggle="yes">in vitro</italic> to T<sub>FH</sub>/B cell co-cultures or the <italic toggle="yes">in vivo</italic> administration to SIV-infected macaques significantly improves memory B cell levels (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B78" ref-type="bibr">78</xref>), suggesting that lost IL-21 production may be a contributing factor to the generation of defective memory B cell responses. T<sub>FH</sub> cells express a number of molecules that restrain them from excessive proliferation such as PD-1 (<xref rid="B53" ref-type="bibr">53</xref>). The PD-1 expression is highly increased in HIV-infected CD4<sup>+</sup> T cells (<xref rid="B31" ref-type="bibr">31</xref>), and the level of its ligand PDL-1 on B cells increases in HIV patients. Interestingly, by blocking the PD-1&#8211;PD-L1 interaction, IL-21 production by T<sub>FH</sub> cells is recovered and B cell functions are restored. Therefore, it is possible that T<sub>FH</sub> cell impairments may be, at least in part, mediated by HIV-associated changes affecting B cells (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>Studies in monkeys have reported that during SIV infection, T<sub>FH</sub> cells express non-characteristic transcriptional factors together with canonical ones and that gene and cytokine expressions are skewed toward CD4<sup>+</sup> Th1&#8201;cells and interferon (IFN)-&#947; (<xref rid="B78" ref-type="bibr">78</xref>). During chronic SIV infection, IFN-&#947;-induced genes are upregulated while the expression of the IL-4 gene is downmodulated (<xref rid="B55" ref-type="bibr">55</xref>). Accordingly, the majority of GC&#8211;T<sub>FH</sub> cells in chronically infected macaques are positive for CXCR3<sup>+</sup> and produce IFN-&#947; (Th1-type cytokine) alongside IL-21. While these cells are capable of helping B cells <italic toggle="yes">in vitro</italic>, they express higher levels of CCR5 and harbor more SIV-DNA than CXCR3<sup>neg</sup> GC&#8211;T<sub>FH</sub> cells (<xref rid="B79" ref-type="bibr">79</xref>). T-bet, the transcriptional regulator of Th1, is also increased in T<sub>FH</sub> cells isolated from SIV-infected macaques&#8217; spleens (<xref rid="B61" ref-type="bibr">61</xref>). Importantly, an association between IFN-&#947;<sup>low</sup> IL-21<sup>hi</sup> GC resident T<sub>FH</sub> cells and the broad neutralization activity against the envelope was found in simian&#8211;human immunodeficiency virus (SHIV)-infected macaques (<xref rid="B80" ref-type="bibr">80</xref>). Taken together, these studies suggest that, while functional, T<sub>FH</sub> cells may undergo changes in levels and function that may affect their ability to help B cells induce high-quality antibodies. These conclusions are corroborated by the lack of responsiveness to other infections or vaccines observed during late HIV/SIV infection.</p></sec><sec id="S1-4"><title>T<sub>FR</sub> Cells and SIV-Associated Changes in Macaques</title><p>T follicular regulatory cells control the magnitude of GC reactions and avoid the onset of some autoimmune diseases (<xref rid="B14" ref-type="bibr">14</xref>&#8211;<xref rid="B17" ref-type="bibr">17</xref>). The frequency of T<sub>FR</sub> cells is low in mice, humans, and monkeys compared to other CD4<sup>+</sup> T cells subsets, and as for the T<sub>FH</sub> cells, the percentage varies depending on the markers used to identify this subset. Phenotypically, they share the canonical markers of T<sub>FH</sub> cells (CXCR5, ICOS, PD-1) and T<sub>REGS</sub> [FOXP3, CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA4) positive and CD127 negative] (Table <xref ref-type="table" rid="T2">2</xref>). Functionally, T<sub>FR</sub> cells produce IL-10 and TGF-&#946; and express the inhibitory molecule CTLA4 (<xref rid="B16" ref-type="bibr">16</xref>). T<sub>FR</sub> cells have been characterized in the LNs of rhesus macaques as FOXP3<sup>pos</sup> CD25<sup>pos</sup> CXCR5<sup>pos</sup> CCR7<sup>neg</sup> as FOXP3<sup>pos</sup> CD25<sup>pos</sup> PD-1<sup>hi</sup> CD127<sup>neg</sup> CXCR5<sup>pos</sup> CD4<sup>+</sup> T cells or, alternatively, as CD25<sup>pos</sup> CD127<sup>neg</sup> CD3<sup>+</sup> CD8<sup>&#8722;</sup> T cells (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>). Depending on the markers used, their frequency ranges between 2 and 5% of CD4<sup>+</sup> T cells or CD8<sup>&#8722;</sup> CD3<sup>+</sup> T cells. We showed that an enriched population of T<sub>FR</sub> cells, obtained from the LNs of macaques by isolating sorted CD25<sup>pos</sup> CD4<sup>+</sup> T cells migrating toward CXCL13, was capable of suppressing autologous GC&#8211;T<sub>FH</sub> cell proliferation <italic toggle="yes">in vitro</italic> (<xref rid="B58" ref-type="bibr">58</xref>).</p><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Markers to define TFR cells in cell suspension in humans and macaques.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Species</th><th valign="top" align="left" rowspan="1" colspan="1">Tissue</th><th valign="top" align="left" rowspan="1" colspan="1">Infection/treatment</th><th valign="top" align="left" rowspan="1" colspan="1">TFH definition</th><th valign="top" align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac251</td><td align="left" valign="top" rowspan="1" colspan="1">CD95<sup>+</sup> FOXP3<sup>+</sup> CD25<sup>+</sup> CXCR5<sup>+</sup> CCR7<sup>&#8722;</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B57" ref-type="bibr">57</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVsmE660</td><td align="left" valign="top" rowspan="1" colspan="1">CXCR5<sup>+</sup> PD-1<sup>hi</sup> FOXP3<sup>+</sup> CD25<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B58" ref-type="bibr">58</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Indian rhesus macaques</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">SIVmac239</td><td align="left" valign="top" rowspan="1" colspan="1">CD3<sup>+</sup> CD8<sup>&#8722;</sup> CD25<sup>hi</sup> CD127<sup>&#8722;</sup> CXCR5<sup>hi</sup> (GC:PD-1<sup>hi</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B82" ref-type="bibr">82</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">Spleen</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CD45RA<sup>&#8722;</sup> CCR7<sup>&#8722;</sup> CXCR5<sup>+</sup> PD-1<sup>+</sup> FOXP3<sup>+</sup> CD25<sup>+</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B29" ref-type="bibr">29</xref>)</td></tr><tr><td align="left" valign="top" colspan="5" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Humans</td><td align="left" valign="top" rowspan="1" colspan="1">LN</td><td align="left" valign="top" rowspan="1" colspan="1">HIV+</td><td align="left" valign="top" rowspan="1" colspan="1">CD3<sup>+</sup> CD8<sup>&#8722;</sup> CD25<sup>hi</sup> CD127<sup>&#8722;</sup> CXCR5<sup>hi</sup></td><td align="center" valign="top" rowspan="1" colspan="1">(<xref rid="B81" ref-type="bibr">81</xref>)</td></tr></tbody></table></table-wrap><p>T<sub>FR</sub> cells are essential to the control of T<sub>FH</sub> cell numbers in mice (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B16" ref-type="bibr">16</xref>). T<sub>FR</sub> cell decrease or stagnation during chronic SIV infection may contribute to the T<sub>FH</sub> cell dynamic seen in HIV infection. Two macaque studies have shown that T<sub>FR</sub> cells are susceptible to infection by different SIV strains: SIV<sub>mac251</sub> and SIV<sub>smE660</sub> (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). A recent study expanded this knowledge to humans by showing that T<sub>FR</sub> cells are highly permissive to infection both <italic toggle="yes">ex vivo</italic> and <italic toggle="yes">in vivo</italic> in chronic HIV-untreated patients (<xref rid="B81" ref-type="bibr">81</xref>). In a longitudinal study in SIV<sub>mac251</sub>-infected macaques, we showed that the frequency and number of T<sub>FR</sub> cells significantly decreased in LNs during the chronic phase and that the reduction was associated with an increase in T<sub>FH</sub> cell levels (<xref rid="B58" ref-type="bibr">58</xref>). These findings were corroborated by the parallel independent study by Chowdhury et al., showing changes in the ratio of T<sub>FH</sub> to T<sub>FR</sub> cells in favor of T<sub>FH</sub> during chronic infection with SIV<sub>smE660</sub> (<xref rid="B59" ref-type="bibr">59</xref>). Interestingly, in a cross-sectional study, Miles et al. showed an increase in the number of GC-resident T<sub>FR</sub> cells in HIV-infected humans and SIV<sub>mac239</sub>-infected macaques. In humans, an increase in the CD4<sup>+</sup> Foxp3<sup>+</sup> cell count was observed when the LN area was considered to account for LN enlargement that occurs during chronic HIV infection (<xref rid="B81" ref-type="bibr">81</xref>). Differences in the study design (longitudinal versus cross-sectional), T<sub>FR</sub> cell definition, and analyses may have contributed to the inconsistent findings in these studies.</p><p>The increase of T<sub>FH</sub> cells in chronic SIV infection has been previously associated with an increase in the titers of gp120-specific antibodies with high avidity (<xref rid="B55" ref-type="bibr">55</xref>). Interestingly, we observed an antithetical role of T<sub>FR</sub> and T<sub>FH</sub> cells in the avidity of antibodies to the SIV-gp120 protein throughout the infection. T<sub>FR</sub> cell levels were associated with a reduction of binding high-avidity antibodies to SIV-gp120 in all the infected animals (<xref rid="B58" ref-type="bibr">58</xref>). The role of T<sub>FR</sub> cells in the impairment of humoral immunity during HIV infection remains to be determined. Finally, T<sub>FR</sub> cells are a relatively newly discovered population, and many of the studies performed on T<sub>FH</sub> cells in humans and macaques did not include markers for T<sub>FR</sub> cells exclusion (Table <xref ref-type="table" rid="T1">1</xref>). Given their changes in frequency, susceptibility to infection and function, discriminating markers for T<sub>FR</sub> should be included when studying T<sub>FH</sub> cells, particularly in HIV vaccine studies.</p></sec><sec id="S1-5"><title>GC-Resident CD8<sup>+</sup> T Cells in Macaques</title><p>GC-resident or CXCR5<sup>pos</sup> CD8<sup>+</sup> T cells are present in lymphoid tissues of humans (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B83" ref-type="bibr">83</xref>&#8211;<xref rid="B85" ref-type="bibr">85</xref>) and macaques (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B31" ref-type="bibr">31</xref>). In fact, three decades ago, high frequencies of CD8<sup>+</sup> T cells were found in inflamed lymphoid follicles in heroin addicts and HIV-related lymphadenopathy (<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>). However, compared to T<sub>FH</sub> cells, current research on the CXCR5<sup>+</sup> CD8<sup>+</sup> T cells is relatively scarce. Several studies suggest that CXCR5<sup>+</sup> CD8<sup>+</sup> T cells represent a subset of follicular cytotoxic CD8<sup>+</sup> T cells and may contribute to virus control in B cell follicles (<xref rid="B23" ref-type="bibr">23</xref>). Indeed, follicular cytotoxic CD8<sup>+</sup> T cells express granzyme A and B and perforin at higher levels than their CXCR5<sup>neg</sup> counterpart (<xref rid="B85" ref-type="bibr">85</xref>). Interestingly, a study identified a subset of CD8<sup>+</sup> T cells with the suppressive activity on T<sub>FH</sub> cells in rhesus macaques&#8217; LNs and humans&#8217; tonsils (<xref rid="B19" ref-type="bibr">19</xref>). CD8<sup>+</sup> with a regulatory function produce IL-10 and express high levels of CXCR5 and the homing cell adhesion molecule CD44. Together these studies suggest that GC-resident CD8<sup>+</sup> T cells may be a heterogeneous cell population.</p><p>The accumulation of infected T<sub>FH</sub> cells in LNs during chronic infection is a major obstacle toward eradication. Cytotoxic CD8<sup>+</sup> T cells are critical for the clearance of virus-infected CD4<sup>+</sup> T cells; thus, studies focused on understanding the phenotype and function of HIV/SIV-specific CD8<sup>+</sup> T cells have been performed in humans and macaques. To date, there are conflicting data on the quantity of specific CXCR5<sup>pos</sup> CD8<sup>+</sup> T cells and their ability to clear virus-infected T<sub>FH</sub> cells. Virus-specific CD8<sup>+</sup> T cells are present in GCs of humans and macaques, but they may not be enough to clear the increasing population of infected T<sub>FH</sub> cells (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>), may be functionally impaired/exhausted (<xref rid="B25" ref-type="bibr">25</xref>), may exert regulatory instead of cytotoxic function, or be predisposed to provide B cell help once they enter the B cell follicles (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Two <italic toggle="yes">in vivo</italic> CD8 cell depletion studies have been performed in SIV-infected macaques (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>). Fukazawa et al. showed that SIV is restricted to CD4<sup>+</sup> T cells in the B cell follicles (with a median of 95% of productively SIV-infected cells) in macaques that are naturally controlling infection (elite controller or EC), but not in animals with normal disease progression. <italic toggle="yes">In vivo</italic> depletion of CD8<sup>+</sup> cells in EC macaques resulted in a temporal redistribution of productive CD4<sup>+</sup> T cells in the extrafollicular area, until CD8<sup>+</sup> T cells absolute count returned to normal levels (<xref rid="B24" ref-type="bibr">24</xref>). Li et al. showed higher levels of both follicular and extrafollicular SIV-producing cells after CD8<sup>+</sup> cell depletion in normal disease progression macaques, with the greatest increase in the extrafollicular areas (8.9 versus 3.8 cells/mm<sup>2</sup> average change in the follicles) (<xref rid="B25" ref-type="bibr">25</xref>). Although these two studies differed in the CD8 depletion protocol (repeated low dose administrations, one single high-dose bolus), both showed profound depletion in the LNs. It should be noted that <italic toggle="yes">in vivo</italic> CD8 cell depletion may have eliminated other CD8-expressing cell populations (for example, NKs).</p><p>Some CXCR5<sup>pos</sup> CD8<sup>+</sup> T cells with the ability to contain LCMV have been found in GCs in mice and in blood of HIV-infected patients (<xref rid="B86" ref-type="bibr">86</xref>), where their levels correlated with viral load. In patients with HIV, the number of virus-specific CXCR5<sup>pos</sup> CD8<sup>+</sup> T cell subset is inversely correlated with viral load in LNs (<xref rid="B86" ref-type="bibr">86</xref>). Peripheral and GC CXCR5<sup>pos</sup> CD8<sup>+</sup> T cells are also present in SIV-infected macaques, where their levels increase after immunization, and it is higher in macaques controlling infection than ones who do not (<xref rid="B87" ref-type="bibr">87</xref>). CD8<sup>+</sup> T cells can still contain viral replication in chronic infections although the mechanism of this containment is largely unknown (<xref rid="B86" ref-type="bibr">86</xref>). Recent work by Petrovas et al. show that CD8<sup>+</sup> T cell in the GC had better killing activity than non-follicular CD8<sup>+</sup> T cells, despite being less polyfunctional (<xref rid="B20" ref-type="bibr">20</xref>). Taken together, these results suggest that CD8<sup>+</sup> T cells could be an effective component of an HIV cure strategy.</p></sec><sec id="S1-6"><title>T<sub>FH</sub> Cells as Privileged Latent Reservoir</title><p>Lymphoid organs constitute the first established reservoir of HIV infection. In untreated HIV patients, viral replication is found in GCs soon after and all through the duration of infection (<xref rid="B88" ref-type="bibr">88</xref>&#8211;<xref rid="B90" ref-type="bibr">90</xref>), and the free virus can be detected even during clinical latency asymptomatic phase (<xref rid="B91" ref-type="bibr">91</xref>, <xref rid="B92" ref-type="bibr">92</xref>). Viral replication is never completely curtailed from the LNs, and it is detected in the GCs till they involute with advancing disease (<xref rid="B93" ref-type="bibr">93</xref>). The macaque model of HIV-1 infection has been fundamental to study B cell follicles as immune privileged sites and for extending these observations to gut-associated lymphoid tissue (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B95" ref-type="bibr">95</xref>). Antiretroviral therapy contains viral replication; however, it fails to eliminate the virus from lymphoid tissues. A steady-state level of very low viremia has also been described among those on ART, but the exact mechanism for persistent viremia during ART is not completely understood (<xref rid="B96" ref-type="bibr">96</xref>). Upon ART discontinuation, viral replication rebounds, resulting in titers similar to those observed prior to treatment. Thus, it is possible that some cellular sanctuary may exist, which allow the virus to persist.</p><p>Recent data suggest that GC&#8211;CXCR5<sup>+</sup>PD-1<sup>hi</sup> T<sub>FH</sub> cells are highly susceptible to HIV-1 infection (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B60" ref-type="bibr">60</xref>). Some studies report that T<sub>FH</sub> cells are a preferentially infected by HIV/SIV (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B57" ref-type="bibr">57</xref>), while others report that the permissiveness of T<sub>FH</sub> cells is comparable to other subsets of memory CD4<sup>+</sup> T cells (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>). The levels of the virus entry co-receptor CCR5 expressed by T<sub>FH</sub> cells varies in different studies (<xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B97" ref-type="bibr">97</xref>), possibly depending on the definition used to identify T<sub>FH</sub> cells. The role of levels of CCR5 expression of T<sub>FH</sub> cells and susceptibility to HIV/SIV infection is also not clear. While a study reports no association between the levels of co-receptor and susceptibility (<xref rid="B60" ref-type="bibr">60</xref>), Xu et al. used NHP to explain the apparent discrepancy between low levels of the HIV co-receptor and the heightened permissiveness to infection (<xref rid="B97" ref-type="bibr">97</xref>). The group identified a subset of LN-resident T<sub>FH</sub> cell precursors expressing intermediate levels of PD-1 and higher levels of CCR5 than fully differentiated PD-1<sup>hi</sup> T<sub>FH</sub> cells and showed that in their precursor state T<sub>FH</sub> cells are highly susceptible to <italic toggle="yes">in vitro</italic> SIV infection. Other parameters may also contribute to the high susceptibility to HIV/SIV infection of T<sub>FH</sub> cells described in certain studies. Recent work by Ruffin et al. showed that GC&#8211;T<sub>FH</sub> cells from LNs and tonsil obtained from chronically infected patients express low levels of the HIV-1 restriction factor SAMHD1 (<xref rid="B98" ref-type="bibr">98</xref>, <xref rid="B99" ref-type="bibr">99</xref>).</p><p>Localization of T<sub>FH</sub> cells within the GCs most likely contributes to their high susceptibility to HIV/SIV infection and their expansion (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B31" ref-type="bibr">31</xref>). The increase in T<sub>FH</sub> cell permissiveness, when compared to other memory CD4<sup>+</sup> T cell subsets, does not associate with their activation status or levels of HIV co-receptor expression (<xref rid="B60" ref-type="bibr">60</xref>). It is possible that their unique localization in the GC may play a role in the heightened susceptibility. Indeed, it has been shown that CD4<sup>+</sup> T cells located in the follicles are 40 times more likely to be infected by HIV than those located outside the follicles (<xref rid="B22" ref-type="bibr">22</xref>). In the GCs, the virus can be transmitted by follicular dendritic cells (FDCs) that are capable of long-term antigen retention (<xref rid="B100" ref-type="bibr">100</xref>). FDCs trap multiple intact viral particles on the surface and efficient transmission to GC-resident CD4<sup>+</sup> T cells (<xref rid="B101" ref-type="bibr">101</xref>&#8211;<xref rid="B104" ref-type="bibr">104</xref>). Indeed, FDCs act as HIV &#8220;archives&#8221; by retaining ART-resistant virus variants that are not present elsewhere (<xref rid="B104" ref-type="bibr">104</xref>). While this is an interesting theory, it is also expected that other molecules may be bound together with the virus, such as antibody and complement, and it is not clear how this trapped virus would serve as a source for CCR5-expressing T<sub>FH</sub> cell precursors (<xref rid="B97" ref-type="bibr">97</xref>). Other HIV-/SIV-associated changes in cellular composition within the GCs, such as changes in T<sub>FH</sub>/T<sub>FR</sub> cell ratio, may contribute to the accumulation of T<sub>FH</sub> cells, at least in macaques (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Moreover, the paucity of virus-specific CD8<sup>+</sup> T cells in the B cell follicles, when compared to extrafollicular areas in both HIV (<xref rid="B22" ref-type="bibr">22</xref>) and SIV infection (<xref rid="B21" ref-type="bibr">21</xref>), as well as cell exhaustion or malfunction, may account for the lack of clearance of infected T<sub>FH</sub> cells as previously described.</p><p>Improving the ability of potent antiviral CD8<sup>+</sup> T cells to traffic into B cell follicles may result in the elimination of virus reservoirs. To determine whether the expression of CXCR5 may be sufficient for CD8<sup>+</sup> T cells to enter the follicles, Ayala et al. infused six SIV-infected macaques with autologous CD8<sup>+</sup> T cells genetically modified to express CXCR5 (<xref rid="B105" ref-type="bibr">105</xref>). The engineered T cells were found in abundance within the B follicles, with some cells localized in the proximity of infected T<sub>FH</sub> cells. While CD8<sup>+</sup> T cells used in this study were circulating T cells that were not selected by their specificity to HIV, this study is an important step forward in the further development of strategies aimed to eliminate virus persistence in treated patients (<xref rid="B105" ref-type="bibr">105</xref>). Finally, a better understanding of immune cell type localization in the GCs, particularly those with the ability to eliminate infected T<sub>FH</sub> cells, will be a key for designing new eradication strategies.</p></sec><sec id="S1-7"><title>Vaccine-Induced T<sub>FH</sub> Cells</title><p>The goal of a vaccine is to induce long-lasting memory responses to the pathogen. HIV presents a greater challenge than other viruses, in part because it replicates in CD4<sup>+</sup> T cells and induces profound deregulation of the overall immune system. Neutralizing antibodies against the autologous virus are detectable only after years from seroconversion and only 20% of infected patients develop cross-react antibodies against different gp120 regions (<xref rid="B106" ref-type="bibr">106</xref>&#8211;<xref rid="B108" ref-type="bibr">108</xref>). Although these antibodies have shown protection in non-human macaques&#8217; models using SHIV (<xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B110" ref-type="bibr">110</xref>), the most desirable response for an HIV vaccine would be the induction of bNabs. bNabs can act against a wide spectrum of viruses by targeting relatively conserved regions on the surface HIV envelope trimer spike (<xref rid="B111" ref-type="bibr">111</xref>). Because of the striking amount of SHM in HIV bNabs (<xref rid="B112" ref-type="bibr">112</xref>&#8211;<xref rid="B114" ref-type="bibr">114</xref>), it is conceivable that T follicular helper cells and GCs play a critical role in generating such antibodies. However, the elicitation of bNabs trough vaccination is challenging. These antibodies are uncommon (produced by 10% of HIV-infected individuals) (<xref rid="B115" ref-type="bibr">115</xref>), and conventional HIV vaccines are unable to induce the number of mutations observed in bNabs. Some studies have been performed in macaques to test the ability of different adjuvants to stimulate T<sub>FH</sub> differentiation, SHMs, and affinity maturation to neutralizing HIV epitopes. Importantly, in this model, the levels of GC-resident T<sub>FH</sub> cells are associated with the generation of neutralizing antibody breadth during SIV/SHIV infection (<xref rid="B80" ref-type="bibr">80</xref>). A study in macaques revealed scarce differences in the mean SHM levels or CDR H3 lengths using eight different adjuvants in combination with a gp140 protein vaccine to immunize macaques (<xref rid="B116" ref-type="bibr">116</xref>). PLGA, a toll-like receptor ligand containing nanoparticles adjuvant, induces strong GCs reactions in monkeys (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>). A native-like Env trimer, given twice intramuscularly together with a strong adjuvant ISCOMATRIX induced neutralizing antibodies against Tier 2 (difficult to neutralize) viruses (<xref rid="B118" ref-type="bibr">118</xref>). Potent T<sub>FH</sub> cell responses were found in LNs of rhesus macaques after immunization, and no changes were observed in the levels of T<sub>FR</sub> cells. The effectiveness of this immunization was not tested in challenge experiments.</p><p>While the search for a strategy capable of bestowing protection <italic toggle="yes">via</italic> the induction of neutralizing antibodies or even bNAbs continues, non-neutralizing antibodies may also be increased during vaccination by increasing T<sub>FH</sub> cell differentiation. Of note, the only vaccine to provide low, but significant protection from HIV acquisition in humans induced binding non-neutralizing antibodies to the variable region of the gp120 V2 loop (<xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B120" ref-type="bibr">120</xref>). In a retrospective study, it was shown that volunteers vaccinated with an ALVAC-SIV&#8201;+&#8201;gp120 alum vaccine had higher levels of IL-21-producing cT<sub>FH</sub> cells than individuals immunized with strategies that failed to protect (<xref rid="B68" ref-type="bibr">68</xref>). Therefore, it is possible that an increase in binding antibodies to gp120, and particularly to the V2 loop, <italic toggle="yes">via</italic> T<sub>FH</sub> cells may increase the efficacy of an HIV vaccine, despite the absence of neutralization. Studies in macaques have revealed that conventional vectored vaccines indeed stimulate T<sub>FH</sub> cells in combination with gp120 or gp140 protein boosts. Codelivery of MVA-SIV and gp120 protein in alum increased the levels of CXCR3<sup>pos</sup> CXCR5<sup>pos</sup> CD4<sup>+</sup> T cells in the blood and LNs of rhesus macaques measured at the peak of immune responses after vaccination. Interestingly, while CXCR3<sup>POS</sup> cT<sub>FH</sub> cells favored antibody responses, they were also associated with increased peak viremia upon infection with SIV<sub>mac251</sub> (<xref rid="B121" ref-type="bibr">121</xref>). An Adenovirus 5- based vector vaccine, encoding for Env, Gag, and Nef, followed by a gp120 or gp140 protein boost induced IL-21-producing T<sub>FH</sub> cells in rhesus macaques&#8217; LNs. T<sub>FH</sub> cell levels measured after 2&#8201;weeks from the last immunization were associated with the titers of binding antibodies to the gp120 (<xref rid="B69" ref-type="bibr">69</xref>). While this vaccine only protected female macaques from SIV<sub>mac251</sub> infection, it is noteworthy that only small differences in the levels of IL-21-producing T<sub>FH</sub> cells were found when animals were stratified by sex. Taken together, these studies suggest that T<sub>FH</sub> cells are induced by different vaccination strategies, and their induction results in potentially protective antibody responses that are measurable in LNs and blood. Studies comparing different strategies side by side should be performed to shed light on the association between the levels and function of T<sub>FH</sub> cell induction and vaccine efficacy.</p></sec></sec><sec id="S2"><title>Conclusion</title><p>The NHP model has played a fundamental role in understanding the dynamics of T<sub>FH</sub> cells during HIV infection and their role as major sites for viral replication and the establishment of viral reservoirs. This model has been a key to the development of new techniques to study T<sub>FH</sub> cells and GC responses that can be translated to humans, and it makes it possible to conduct preclinical studies aimed at eradicating HIV. Undoubtedly a fuller appreciation for the range of cells participating in meaningful cellular reservoirs could result in a rational attack on latent HIV-1 and may provide inroads into creating an effective vaccine designed to generate HIV neutralizing antibodies. However, the obvious limitation is that NHPs are not humans. Much of what is learned from non-human primates, especially at the preclinical level, must be validate in humans.</p></sec><sec id="S3"><title>Author Contributions</title><p>MV drafted the manuscript. MV and GF critically revised the manuscript.</p></sec><sec id="S4"><title>Conflict of Interest Statement</title><p>The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in the manuscript.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> No funding for writing assistance was utilized in the production of this manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plotkin</surname><given-names>SA</given-names></name></person-group>. <article-title>Vaccines: correlates of vaccine-induced immunity</article-title>. <source>Clin Infect Dis</source> (<year>2008</year>) <volume>47</volume>:<fpage>401</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1086/589862</pub-id><pub-id pub-id-type="pmid">18558875</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gunn</surname><given-names>MD</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>VN</given-names></name><name name-style="western"><surname>Ansel</surname><given-names>KM</given-names></name><name name-style="western"><surname>Ekland</surname><given-names>EH</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name><name name-style="western"><surname>Williams</surname><given-names>LT</given-names></name></person-group>. <article-title>A B-cell-homing chemokine made in lymphoid follicles activates Burkitt&#8217;s lymphoma receptor-1</article-title>. <source>Nature</source> (<year>1998</year>) <volume>391</volume>:<fpage>799</fpage>&#8211;<lpage>803</lpage>.<pub-id pub-id-type="doi">10.1038/35876</pub-id><pub-id pub-id-type="pmid">9486651</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ansel</surname><given-names>KM</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>VN</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>MG</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines</article-title>. <source>J Exp Med</source> (<year>1999</year>) <volume>190</volume>:<fpage>1123</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1084/jem.190.8.1123</pub-id><pub-id pub-id-type="pmid">10523610</pub-id><pub-id pub-id-type="pmcid">PMC2195660</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Breitfeld</surname><given-names>D</given-names></name><name name-style="western"><surname>Ohl</surname><given-names>L</given-names></name><name name-style="western"><surname>Kremmer</surname><given-names>E</given-names></name><name name-style="western"><surname>Ellwart</surname><given-names>J</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Lipp</surname><given-names>M</given-names></name><etal/></person-group><article-title>Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>192</volume>:<fpage>1545</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1084/jem.192.11.1545</pub-id><pub-id pub-id-type="pmid">11104797</pub-id><pub-id pub-id-type="pmcid">PMC2193094</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>CH</given-names></name><name name-style="western"><surname>Rott</surname><given-names>LS</given-names></name><name name-style="western"><surname>Clark-Lewis</surname><given-names>I</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><name name-style="western"><surname>Butcher</surname><given-names>EC</given-names></name></person-group>. <article-title>Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells</article-title>. <source>J Exp Med</source> (<year>2001</year>) <volume>193</volume>:<fpage>1373</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1084/jem.193.12.1373</pub-id><pub-id pub-id-type="pmid">11413192</pub-id><pub-id pub-id-type="pmcid">PMC2193300</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hardtke</surname><given-names>S</given-names></name><name name-style="western"><surname>Ohl</surname><given-names>L</given-names></name><name name-style="western"><surname>Forster</surname><given-names>R</given-names></name></person-group>. <article-title>Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help</article-title>. <source>Blood</source> (<year>2005</year>) <volume>106</volume>:<fpage>1924</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2004-11-4494</pub-id><pub-id pub-id-type="pmid">15899919</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaerli</surname><given-names>P</given-names></name><name name-style="western"><surname>Willimann</surname><given-names>K</given-names></name><name name-style="western"><surname>Lang</surname><given-names>AB</given-names></name><name name-style="western"><surname>Lipp</surname><given-names>M</given-names></name><name name-style="western"><surname>Loetscher</surname><given-names>P</given-names></name><name name-style="western"><surname>Moser</surname><given-names>B</given-names></name></person-group>. <article-title>CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>192</volume>:<fpage>1553</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1084/jem.192.11.1553</pub-id><pub-id pub-id-type="pmid">11104798</pub-id><pub-id pub-id-type="pmcid">PMC2193097</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de Vinuesa</surname><given-names>CG</given-names></name><name name-style="western"><surname>Cook</surname><given-names>MC</given-names></name><name name-style="western"><surname>Ball</surname><given-names>J</given-names></name><name name-style="western"><surname>Drew</surname><given-names>M</given-names></name><name name-style="western"><surname>Sunners</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cascalho</surname><given-names>M</given-names></name><etal/></person-group><article-title>Germinal centers without T cells</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>191</volume>:<fpage>485</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1084/jem.191.3.485</pub-id><pub-id pub-id-type="pmid">10662794</pub-id><pub-id pub-id-type="pmcid">PMC2195827</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S</given-names></name></person-group>. <article-title>Follicular helper CD4 T cells (TFH)</article-title>. <source>Annu Rev Immunol</source> (<year>2011</year>) <volume>29</volume>:<fpage>621</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101400</pub-id><pub-id pub-id-type="pmid">21314428</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toellner</surname><given-names>KM</given-names></name><name name-style="western"><surname>Jenkinson</surname><given-names>WE</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>DR</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M</given-names></name><name name-style="western"><surname>Sze</surname><given-names>DM</given-names></name><name name-style="western"><surname>Sansom</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>195</volume>:<fpage>383</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20011112</pub-id><pub-id pub-id-type="pmid">11828014</pub-id><pub-id pub-id-type="pmcid">PMC2193598</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>MacLennan</surname><given-names>IC</given-names></name></person-group>. <article-title>Germinal centers</article-title>. <source>Annu Rev Immunol</source> (<year>1994</year>) <volume>12</volume>:<fpage>117</fpage>&#8211;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.iy.12.040194.001001</pub-id><pub-id pub-id-type="pmid">8011279</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodnow</surname><given-names>CC</given-names></name><name name-style="western"><surname>Vinuesa</surname><given-names>CG</given-names></name><name name-style="western"><surname>Randall</surname><given-names>KL</given-names></name><name name-style="western"><surname>Mackay</surname><given-names>F</given-names></name><name name-style="western"><surname>Brink</surname><given-names>R</given-names></name></person-group>. <article-title>Control systems and decision making for antibody production</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<fpage>681</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1900</pub-id><pub-id pub-id-type="pmid">20644574</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Silva</surname><given-names>NS</given-names></name><name name-style="western"><surname>Klein</surname><given-names>U</given-names></name></person-group>. <article-title>Dynamics of B cells in germinal centres</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>:<fpage>137</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1038/nri3804</pub-id><pub-id pub-id-type="pmid">25656706</pub-id><pub-id pub-id-type="pmcid">PMC4399774</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Chu</surname><given-names>F</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>RI</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Rawal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions</article-title>. <source>Nat Med</source> (<year>2011</year>) <volume>17</volume>:<fpage>983</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nm.2426</pub-id><pub-id pub-id-type="pmid">21785430</pub-id><pub-id pub-id-type="pmcid">PMC3151340</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wollenberg</surname><given-names>I</given-names></name><name name-style="western"><surname>Agua-Doce</surname><given-names>A</given-names></name><name name-style="western"><surname>Hern&#225;ndez</surname><given-names>A</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>C</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>VG</given-names></name><name name-style="western"><surname>Faro</surname><given-names>J</given-names></name><etal/></person-group><article-title>Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>4553</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1101328</pub-id><pub-id pub-id-type="pmid">21984700</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pierson</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Foxp3+ follicular regulatory T cells control the germinal center response</article-title>. <source>Nat Med</source> (<year>2011</year>) <volume>17</volume>:<fpage>975</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1038/nm.2425</pub-id><pub-id pub-id-type="pmid">21785433</pub-id><pub-id pub-id-type="pmcid">PMC3182542</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alexander</surname><given-names>CM</given-names></name><name name-style="western"><surname>Tygrett</surname><given-names>LT</given-names></name><name name-style="western"><surname>Boyden</surname><given-names>AW</given-names></name><name name-style="western"><surname>Wolniak</surname><given-names>KL</given-names></name><name name-style="western"><surname>Legge</surname><given-names>KL</given-names></name><name name-style="western"><surname>Waldschmidt</surname><given-names>TJ</given-names></name></person-group>. <article-title>T regulatory cells participate in the control of germinal centre reactions</article-title>. <source>Immunology</source> (<year>2011</year>) <volume>133</volume>:<fpage>452</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2011.03456.x</pub-id><pub-id pub-id-type="pmid">21635248</pub-id><pub-id pub-id-type="pmcid">PMC3143357</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quigley</surname><given-names>MF</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>VD</given-names></name><name name-style="western"><surname>Granath</surname><given-names>A</given-names></name><name name-style="western"><surname>Andersson</surname><given-names>J</given-names></name><name name-style="western"><surname>Sandberg</surname><given-names>JK</given-names></name></person-group>. <article-title>CXCR5+ CCR7- CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles</article-title>. <source>Eur J Immunol</source> (<year>2007</year>) <volume>37</volume>:<fpage>3352</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200636746</pub-id><pub-id pub-id-type="pmid">18000950</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miles</surname><given-names>B</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SM</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Levy</surname><given-names>DN</given-names></name><name name-style="western"><surname>Rakasz</surname><given-names>EG</given-names></name><name name-style="western"><surname>Skinner</surname><given-names>PJ</given-names></name><etal/></person-group><article-title>Follicular regulatory CD8 T cells impair the germinal center response in SIV and ex vivo HIV infection</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005924</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1005924</pub-id><pub-id pub-id-type="pmid">27716848</pub-id><pub-id pub-id-type="pmcid">PMC5055335</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrovas</surname><given-names>C</given-names></name><name name-style="western"><surname>Ferrando-Martinez</surname><given-names>S</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>MY</given-names></name><name name-style="western"><surname>Casazza</surname><given-names>JP</given-names></name><name name-style="western"><surname>Pegu</surname><given-names>A</given-names></name><name name-style="western"><surname>Deleage</surname><given-names>C</given-names></name><etal/></person-group><article-title>Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies</article-title>. <source>Sci Transl Med</source> (<year>2017</year>) <volume>9</volume>:<fpage>eaag2285</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aag2285</pub-id><pub-id pub-id-type="pmid">28100833</pub-id><pub-id pub-id-type="pmcid">PMC5497679</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Connick</surname><given-names>E</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lind</surname><given-names>KT</given-names></name><name name-style="western"><surname>Rakasz</surname><given-names>EG</given-names></name><name name-style="western"><surname>Miles</surname><given-names>B</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>NA</given-names></name><etal/></person-group><article-title>Compartmentalization of simian immunodeficiency virus replication within secondary lymphoid tissues of rhesus macaques is linked to disease stage and inversely related to localization of virus-specific CTL</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>5613</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401161</pub-id><pub-id pub-id-type="pmid">25362178</pub-id><pub-id pub-id-type="pmcid">PMC4239212</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Connick</surname><given-names>E</given-names></name><name name-style="western"><surname>Mattila</surname><given-names>T</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Schlichtemeier</surname><given-names>R</given-names></name><name name-style="western"><surname>Meditz</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ray</surname><given-names>MG</given-names></name><etal/></person-group><article-title>CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>6975</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.11.6975</pub-id><pub-id pub-id-type="pmid">17513747</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leong</surname><given-names>YA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ong</surname><given-names>HS</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Man</surname><given-names>K</given-names></name><name name-style="western"><surname>Deleage</surname><given-names>C</given-names></name><etal/></person-group><article-title>CXCR5(+) follicular cytotoxic T cells control viral infection in B cell follicles</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>1187</fpage>&#8211;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3543</pub-id><pub-id pub-id-type="pmid">27487330</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fukazawa</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lum</surname><given-names>R</given-names></name><name name-style="western"><surname>Okoye</surname><given-names>AA</given-names></name><name name-style="western"><surname>Park</surname><given-names>H</given-names></name><name name-style="western"><surname>Matsuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Bae</surname><given-names>JY</given-names></name><etal/></person-group><article-title>B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers</article-title>. <source>Nat Med</source> (<year>2015</year>) <volume>21</volume>:<fpage>132</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3781</pub-id><pub-id pub-id-type="pmid">25599132</pub-id><pub-id pub-id-type="pmcid">PMC4320022</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Rakasz</surname><given-names>EG</given-names></name><name name-style="western"><surname>Abdelaal</surname><given-names>HM</given-names></name><name name-style="western"><surname>Wagstaff</surname><given-names>RK</given-names></name><name name-style="western"><surname>Kovacs</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Simian immunodeficiency virus-producing cells in follicles are partially suppressed by CD8+ cells in vivo</article-title>. <source>J Virol</source> (<year>2016</year>) <volume>90</volume>:<fpage>11168</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01332-16</pub-id><pub-id pub-id-type="pmid">27707919</pub-id><pub-id pub-id-type="pmcid">PMC5126374</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moir</surname><given-names>S</given-names></name><name name-style="western"><surname>Fauci</surname><given-names>AS</given-names></name></person-group><article-title>B cells in HIV infection and disease</article-title>. <source>Nat Rev Immunol</source> (<year>2009</year>) <volume>9</volume>:<fpage>235</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/nri2524</pub-id><pub-id pub-id-type="pmid">19319142</pub-id><pub-id pub-id-type="pmcid">PMC2779527</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perreau</surname><given-names>M</given-names></name><name name-style="western"><surname>Savoye</surname><given-names>AL</given-names></name><name name-style="western"><surname>De Crignis</surname><given-names>E</given-names></name><name name-style="western"><surname>Corpataux</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cubas</surname><given-names>R</given-names></name><name name-style="western"><surname>Haddad</surname><given-names>EK</given-names></name><etal/></person-group><article-title>Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<fpage>143</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20121932</pub-id><pub-id pub-id-type="pmid">23254284</pub-id><pub-id pub-id-type="pmcid">PMC3549706</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindqvist</surname><given-names>M</given-names></name><name name-style="western"><surname>van Lunzen</surname><given-names>J</given-names></name><name name-style="western"><surname>Soghoian</surname><given-names>DZ</given-names></name><name name-style="western"><surname>Kuhl</surname><given-names>BD</given-names></name><name name-style="western"><surname>Ranasinghe</surname><given-names>S</given-names></name><name name-style="western"><surname>Kranias</surname><given-names>G</given-names></name><etal/></person-group><article-title>Expansion of HIV-specific T follicular helper cells in chronic HIV infection</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>:<fpage>3271</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1172/JCI64314</pub-id><pub-id pub-id-type="pmid">22922259</pub-id><pub-id pub-id-type="pmcid">PMC3428098</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colineau</surname><given-names>L</given-names></name><name name-style="western"><surname>Rouers</surname><given-names>A</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Urrutia</surname><given-names>A</given-names></name><name name-style="western"><surname>Pham</surname><given-names>HP</given-names></name><etal/></person-group><article-title>HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0140978</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0140978</pub-id><pub-id pub-id-type="pmid">26501424</pub-id><pub-id pub-id-type="pmcid">PMC4621058</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cubas</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mudd</surname><given-names>JC</given-names></name><name name-style="western"><surname>Savoye</surname><given-names>AL</given-names></name><name name-style="western"><surname>Perreau</surname><given-names>M</given-names></name><name name-style="western"><surname>van Grevenynghe</surname><given-names>J</given-names></name><name name-style="western"><surname>Metcalf</surname><given-names>T</given-names></name><etal/></person-group><article-title>Inadequate T follicular cell help impairs B cell immunity during HIV infection</article-title>. <source>Nat Med</source> (<year>2013</year>) <volume>19</volume>:<fpage>494</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nm.3109</pub-id><pub-id pub-id-type="pmid">23475201</pub-id><pub-id pub-id-type="pmcid">PMC3843317</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Amancha</surname><given-names>PK</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>K</given-names></name><name name-style="western"><surname>Ansari</surname><given-names>AA</given-names></name><name name-style="western"><surname>Villinger</surname><given-names>F</given-names></name></person-group>. <article-title>Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>3247</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1103138</pub-id><pub-id pub-id-type="pmid">22387550</pub-id><pub-id pub-id-type="pmcid">PMC3311732</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>F</given-names></name><name name-style="western"><surname>Mouquet</surname><given-names>H</given-names></name><name name-style="western"><surname>Dosenovic</surname><given-names>P</given-names></name><name name-style="western"><surname>Scheid</surname><given-names>JF</given-names></name><name name-style="western"><surname>Scharf</surname><given-names>L</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>MC</given-names></name></person-group>. <article-title>Antibodies in HIV-1 vaccine development and therapy</article-title>. <source>Science</source> (<year>2013</year>) <volume>341</volume>:<fpage>1199</fpage>&#8211;<lpage>204</lpage>.<pub-id pub-id-type="doi">10.1126/science.1241144</pub-id><pub-id pub-id-type="pmid">24031012</pub-id><pub-id pub-id-type="pmcid">PMC3970325</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chalifoux</surname><given-names>LV</given-names></name><name name-style="western"><surname>Ringler</surname><given-names>DJ</given-names></name><name name-style="western"><surname>King</surname><given-names>NW</given-names></name><name name-style="western"><surname>Sehgal</surname><given-names>PK</given-names></name><name name-style="western"><surname>Desrosiers</surname><given-names>RC</given-names></name><name name-style="western"><surname>Daniel</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV)</article-title>. <source>Am J Pathol</source> (<year>1987</year>) <volume>128</volume>:<fpage>104</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">3037910</pub-id><pub-id pub-id-type="pmcid">PMC1899782</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>RI</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XO</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Ma</surname><given-names>L</given-names></name><etal/></person-group><article-title>Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>29</volume>:<fpage>138</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.009</pub-id><pub-id pub-id-type="pmid">18599325</pub-id><pub-id pub-id-type="pmcid">PMC2556461</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Rhesus Macaque Genome Sequencing and Analysis Consortium</collab><name name-style="western"><surname>Gibbs</surname><given-names>RA</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>J</given-names></name><name name-style="western"><surname>Katze</surname><given-names>MG</given-names></name><name name-style="western"><surname>Bumgarner</surname><given-names>R</given-names></name><name name-style="western"><surname>Weinstock</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Evolutionary and biomedical insights from the rhesus macaque genome</article-title>. <source>Science</source> (<year>2007</year>) <volume>316</volume>:<fpage>222</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1126/science.1139247</pub-id><pub-id pub-id-type="pmid">17431167</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Seok</surname><given-names>J</given-names></name><name name-style="western"><surname>Warren</surname><given-names>HS</given-names></name><name name-style="western"><surname>Cuenca</surname><given-names>AG</given-names></name><name name-style="western"><surname>Mindrinos</surname><given-names>MN</given-names></name><name name-style="western"><surname>Baker</surname><given-names>HV</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Genomic responses in mouse models poorly mimic human inflammatory diseases</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2013</year>) <volume>110</volume>:<fpage>3507</fpage>&#8211;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1222878110</pub-id><pub-id pub-id-type="pmid">23401516</pub-id><pub-id pub-id-type="pmcid">PMC3587220</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locci</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JE</given-names></name><name name-style="western"><surname>Arumemi</surname><given-names>F</given-names></name><name name-style="western"><surname>Mikulski</surname><given-names>Z</given-names></name><name name-style="western"><surname>Dahlberg</surname><given-names>C</given-names></name><name name-style="western"><surname>Miller</surname><given-names>AT</given-names></name><etal/></person-group><article-title>Activin A programs the differentiation of human TFH cells</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>:<fpage>976</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3494</pub-id><pub-id pub-id-type="pmid">27376469</pub-id><pub-id pub-id-type="pmcid">PMC4955732</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pitcher</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>SI</given-names></name><name name-style="western"><surname>Walker</surname><given-names>JM</given-names></name><name name-style="western"><surname>Lum</surname><given-names>R</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>BL</given-names></name><name name-style="western"><surname>Maino</surname><given-names>VC</given-names></name><etal/></person-group><article-title>Development and homeostasis of T cell memory in rhesus macaque</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume>:<fpage>29</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.168.1.29</pub-id><pub-id pub-id-type="pmid">11751943</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hasegawa</surname><given-names>A</given-names></name><name name-style="western"><surname>Moriya</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Charini</surname><given-names>WA</given-names></name><name name-style="western"><surname>Vinet</surname><given-names>HC</given-names></name><name name-style="western"><surname>Subbramanian</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Analysis of TCRalphabeta combinations used by simian immunodeficiency virus-specific CD8+ T cells in rhesus monkeys: implications for CTL immunodominance</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>3409</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.6.3409</pub-id><pub-id pub-id-type="pmid">17339435</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cicin-Sain</surname><given-names>L</given-names></name><name name-style="western"><surname>Messaoudi</surname><given-names>I</given-names></name><name name-style="western"><surname>Park</surname><given-names>B</given-names></name><name name-style="western"><surname>Currier</surname><given-names>N</given-names></name><name name-style="western"><surname>Planer</surname><given-names>S</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>:<fpage>19960</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0705905104</pub-id><pub-id pub-id-type="pmid">18056811</pub-id><pub-id pub-id-type="pmcid">PMC2148405</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haley</surname><given-names>PJ</given-names></name></person-group>. <article-title>The lymphoid system: a review of species differences</article-title>. <source>J Toxicol Pathol</source> (<year>2017</year>) <volume>30</volume>:<fpage>111</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1293/tox.2016-0075</pub-id><pub-id pub-id-type="pmid">28458449</pub-id><pub-id pub-id-type="pmcid">PMC5406590</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garside</surname><given-names>P</given-names></name><name name-style="western"><surname>Ingulli</surname><given-names>E</given-names></name><name name-style="western"><surname>Merica</surname><given-names>RR</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>JG</given-names></name><name name-style="western"><surname>Noelle</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Jenkins</surname><given-names>MK</given-names></name></person-group>. <article-title>Visualization of specific B and T lymphocyte interactions in the lymph node</article-title>. <source>Science</source> (<year>1998</year>) <volume>281</volume>:<fpage>96</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.281.5373.96</pub-id><pub-id pub-id-type="pmid">9651253</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okada</surname><given-names>T</given-names></name><name name-style="western"><surname>Miller</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Parker</surname><given-names>I</given-names></name><name name-style="western"><surname>Krummel</surname><given-names>MF</given-names></name><name name-style="western"><surname>Neighbors</surname><given-names>M</given-names></name><name name-style="western"><surname>Hartley</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Antigen-engaged B cells undergo chemotaxis toward the T zone and form motile conjugates with helper T cells</article-title>. <source>PLoS Biol</source> (<year>2005</year>) <volume>3</volume>:<fpage>e150</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pbio.0030150</pub-id><pub-id pub-id-type="pmid">15857154</pub-id><pub-id pub-id-type="pmcid">PMC1088276</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qi</surname><given-names>H</given-names></name><name name-style="western"><surname>Cannons</surname><given-names>JL</given-names></name><name name-style="western"><surname>Klauschen</surname><given-names>F</given-names></name><name name-style="western"><surname>Schwartzberg</surname><given-names>PL</given-names></name><name name-style="western"><surname>Germain</surname><given-names>RN</given-names></name></person-group>. <article-title>SAP-controlled T-B cell interactions underlie germinal centre formation</article-title>. <source>Nature</source> (<year>2008</year>) <volume>455</volume>:<fpage>764</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature07345</pub-id><pub-id pub-id-type="pmid">18843362</pub-id><pub-id pub-id-type="pmcid">PMC2652134</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><name name-style="western"><surname>Lindgren</surname><given-names>G</given-names></name><name name-style="western"><surname>Sandgren</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name><name name-style="western"><surname>Francica</surname><given-names>JR</given-names></name><name name-style="western"><surname>Seubert</surname><given-names>A</given-names></name><etal/></person-group><article-title>Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake</article-title>. <source>Sci Transl Med</source> (<year>2017</year>) <volume>9</volume>:<fpage>eaal2094</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aal2094</pub-id><pub-id pub-id-type="pmid">28592561</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Silveira</surname><given-names>ELDV</given-names></name><name name-style="western"><surname>Amancha</surname><given-names>PK</given-names></name><name name-style="western"><surname>Byrareddy</surname><given-names>SN</given-names></name><name name-style="western"><surname>Gumber</surname><given-names>S</given-names></name><name name-style="western"><surname>Chang</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Early initiation of antiretroviral treatment postSIV infection does not resolve lymphoid tissue activation</article-title>. <source>AIDS</source> (<year>2017</year>) <volume>31</volume>:<fpage>1819</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1097/QAD.0000000000001576</pub-id><pub-id pub-id-type="pmid">28692537</pub-id><pub-id pub-id-type="pmcid">PMC5557084</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peruchon</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaoul</surname><given-names>N</given-names></name><name name-style="western"><surname>Burelout</surname><given-names>C</given-names></name><name name-style="western"><surname>Delache</surname><given-names>B</given-names></name><name name-style="western"><surname>Brochard</surname><given-names>P</given-names></name><name name-style="western"><surname>Laurent</surname><given-names>P</given-names></name><etal/></person-group><article-title>Tissue-specific B-cell dysfunction and generalized memory B-cell loss during acute SIV infection</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>:<fpage>e5966</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0005966</pub-id><pub-id pub-id-type="pmid">19543531</pub-id><pub-id pub-id-type="pmcid">PMC2695011</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demberg</surname><given-names>T</given-names></name><name name-style="western"><surname>Mohanram</surname><given-names>V</given-names></name><name name-style="western"><surname>Musich</surname><given-names>T</given-names></name><name name-style="western"><surname>Brocca-Cofano</surname><given-names>E</given-names></name><name name-style="western"><surname>McKinnon</surname><given-names>KM</given-names></name><name name-style="western"><surname>Venzon</surname><given-names>D</given-names></name><etal/></person-group><article-title>Loss of marginal zone B-cells in SHIVSF162P4 challenged rhesus macaques despite control of viremia to low or undetectable levels in chronic infection</article-title>. <source>Virology</source> (<year>2015</year>) <volume>484</volume>:<fpage>323</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.virol.2015.06.022</pub-id><pub-id pub-id-type="pmid">26151223</pub-id><pub-id pub-id-type="pmcid">PMC4567457</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardner</surname><given-names>MB</given-names></name><name name-style="western"><surname>Luciw</surname><given-names>PA</given-names></name></person-group>. <article-title>Macaque models of human infectious disease</article-title>. <source>ILAR J</source> (<year>2008</year>) <volume>49</volume>:<fpage>220</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1093/ilar.49.2.220</pub-id><pub-id pub-id-type="pmid">18323583</pub-id><pub-id pub-id-type="pmcid">PMC7108592</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fernandez</surname><given-names>C</given-names></name><name name-style="western"><surname>Alcantara</surname><given-names>S</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>M</given-names></name><name name-style="western"><surname>De Rose</surname><given-names>R</given-names></name><name name-style="western"><surname>Kelleher</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Serial study of lymph node cell subsets using fine needle aspiration in pigtail macaques</article-title>. <source>J Immunol Methods</source> (<year>2013</year>) <volume>394</volume>:<fpage>73</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.jim.2013.05.005</pub-id><pub-id pub-id-type="pmid">23702165</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klippert</surname><given-names>A</given-names></name><name name-style="western"><surname>Stolte-Leeb</surname><given-names>N</given-names></name><name name-style="western"><surname>Neumann</surname><given-names>B</given-names></name><name name-style="western"><surname>Sauermann</surname><given-names>U</given-names></name><name name-style="western"><surname>Daskalaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Gawanbacht</surname><given-names>A</given-names></name><etal/></person-group><article-title>Frequencies of lymphoid T-follicular helper cells obtained longitudinally by lymph node fine-needle aspiration correlate significantly with viral load in SIV-infected rhesus monkeys</article-title>. <source>J Med Primatol</source> (<year>2015</year>) <volume>44</volume>:<fpage>253</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1111/jmp.12186</pub-id><pub-id pub-id-type="pmid">26227257</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nurieva</surname><given-names>RI</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XO</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Matskevitch</surname><given-names>TD</given-names></name><etal/></person-group><article-title>Bcl6 mediates the development of T follicular helper cells</article-title>. <source>Science</source> (<year>2009</year>) <volume>325</volume>:<fpage>1001</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1176676</pub-id><pub-id pub-id-type="pmid">19628815</pub-id><pub-id pub-id-type="pmcid">PMC2857334</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crotty</surname><given-names>S</given-names></name></person-group>. <article-title>T follicular helper cell differentiation, function, and roles in disease</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<fpage>529</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.004</pub-id><pub-id pub-id-type="pmid">25367570</pub-id><pub-id pub-id-type="pmcid">PMC4223692</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weatherall</surname><given-names>C</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>M</given-names></name><name name-style="western"><surname>Alcantara</surname><given-names>S</given-names></name><name name-style="western"><surname>De Rose</surname><given-names>R</given-names></name><name name-style="western"><surname>Estaquier</surname><given-names>J</given-names></name><etal/></person-group><article-title>Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques</article-title>. <source>J Virol</source> (<year>2013</year>) <volume>87</volume>:<fpage>3760</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02497-12</pub-id><pub-id pub-id-type="pmid">23325697</pub-id><pub-id pub-id-type="pmcid">PMC3624224</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrovas</surname><given-names>C</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Gerner</surname><given-names>MY</given-names></name><name name-style="western"><surname>Boswell</surname><given-names>KL</given-names></name><name name-style="western"><surname>Wloka</surname><given-names>K</given-names></name><name name-style="western"><surname>Smith</surname><given-names>EC</given-names></name><etal/></person-group><article-title>CD4 T follicular helper cell dynamics during SIV infection</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>:<fpage>3281</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1172/JCI63039</pub-id><pub-id pub-id-type="pmid">22922258</pub-id><pub-id pub-id-type="pmcid">PMC3428091</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onabajo</surname><given-names>OO</given-names></name><name name-style="western"><surname>George</surname><given-names>J</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>MG</given-names></name><name name-style="western"><surname>Mattapallil</surname><given-names>JJ</given-names></name></person-group>. <article-title>Rhesus macaque lymph node PD-1(hi)CD4+ T cells express high levels of CXCR5 and IL-21 and display a CCR7(lo)ICOS+Bcl6+ T-follicular helper (Tfh) cell phenotype</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e59758</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0059758</pub-id><pub-id pub-id-type="pmid">23527264</pub-id><pub-id pub-id-type="pmcid">PMC3602102</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blackburn</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zhong-Min</surname><given-names>M</given-names></name><name name-style="western"><surname>Caccuri</surname><given-names>F</given-names></name><name name-style="western"><surname>McKinnon</surname><given-names>K</given-names></name><name name-style="western"><surname>Schifanella</surname><given-names>L</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Regulatory and helper follicular T cells and antibody avidity to simian immunodeficiency virus glycoprotein 120</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<fpage>3227</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402699</pub-id><pub-id pub-id-type="pmid">26297759</pub-id><pub-id pub-id-type="pmcid">PMC4575875</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chowdhury</surname><given-names>A</given-names></name><name name-style="western"><surname>Del Rio Estrada</surname><given-names>PM</given-names></name><name name-style="western"><surname>Tharp</surname><given-names>GK</given-names></name><name name-style="western"><surname>Trible</surname><given-names>RP</given-names></name><name name-style="western"><surname>Amara</surname><given-names>RR</given-names></name><name name-style="western"><surname>Chahroudi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Decreased T follicular regulatory cell/T follicular helper cell (TFH) in simian immunodeficiency virus-infected rhesus macaques may contribute to accumulation of TFH in chronic infection</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<fpage>3237</fpage>&#8211;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402701</pub-id><pub-id pub-id-type="pmid">26297764</pub-id><pub-id pub-id-type="pmcid">PMC4575868</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Lackner</surname><given-names>AA</given-names></name><name name-style="western"><surname>Veazey</surname><given-names>RS</given-names></name></person-group>. <article-title>PD-1(HIGH) follicular CD4 T helper cell subsets residing in lymph node germinal centers correlate with B cell maturation and IgG production in rhesus macaques</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>85</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00085</pub-id><pub-id pub-id-type="pmid">24678309</pub-id><pub-id pub-id-type="pmcid">PMC3958750</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohler</surname><given-names>SL</given-names></name><name name-style="western"><surname>Pham</surname><given-names>MN</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Arends</surname><given-names>T</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SM</given-names></name><name name-style="western"><surname>Miles</surname><given-names>B</given-names></name><etal/></person-group><article-title>Germinal center T follicular helper cells are highly permissive to HIV-1 and alter their phenotype during virus replication</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>:<fpage>2711</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1502174</pub-id><pub-id pub-id-type="pmid">26873986</pub-id><pub-id pub-id-type="pmcid">PMC4779697</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moukambi</surname><given-names>F</given-names></name><name name-style="western"><surname>Rabezanahary</surname><given-names>H</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>V</given-names></name><name name-style="western"><surname>Racine</surname><given-names>G</given-names></name><name name-style="western"><surname>Robitaille</surname><given-names>L</given-names></name><name name-style="western"><surname>Krust</surname><given-names>B</given-names></name><etal/></person-group><article-title>Early loss of splenic Tfh cells in SIV-infected rhesus macaques</article-title>. <source>PLoS Pathog</source> (<year>2016</year>) <volume>12</volume>:<fpage>e1005393</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005393</pub-id><pub-id pub-id-type="pmid">26760303</pub-id><pub-id pub-id-type="pmcid">PMC4712012</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Malam</surname><given-names>N</given-names></name><name name-style="western"><surname>Aye</surname><given-names>PP</given-names></name><name name-style="western"><surname>Alvarez</surname><given-names>X</given-names></name><name name-style="western"><surname>Lackner</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Persistent simian immunodeficiency virus infection drives differentiation, aberrant accumulation, and latent infection of germinal center follicular T helper cells</article-title>. <source>J Virol</source> (<year>2015</year>) <volume>90</volume>:<fpage>1578</fpage>&#8211;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02471-15</pub-id><pub-id pub-id-type="pmid">26608323</pub-id><pub-id pub-id-type="pmcid">PMC4719631</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morita</surname><given-names>R</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>N</given-names></name><name name-style="western"><surname>Bentebibel</surname><given-names>SE</given-names></name><name name-style="western"><surname>Ranganathan</surname><given-names>R</given-names></name><name name-style="western"><surname>Bourdery</surname><given-names>L</given-names></name><name name-style="western"><surname>Zurawski</surname><given-names>G</given-names></name><etal/></person-group><article-title>Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>108</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.012</pub-id><pub-id pub-id-type="pmid">21215658</pub-id><pub-id pub-id-type="pmcid">PMC3046815</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locci</surname><given-names>M</given-names></name><name name-style="western"><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name name-style="western"><surname>Landais</surname><given-names>E</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Kroenke</surname><given-names>MA</given-names></name><name name-style="western"><surname>Arlehamn</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>758</fpage>&#8211;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.031</pub-id><pub-id pub-id-type="pmid">24035365</pub-id><pub-id pub-id-type="pmcid">PMC3996844</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name name-style="western"><surname>Lindqvist</surname><given-names>M</given-names></name><name name-style="western"><surname>Heit</surname><given-names>A</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JE</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>SM</given-names></name><name name-style="western"><surname>Kendric</surname><given-names>K</given-names></name><etal/></person-group><article-title>CXCL13 is a plasma biomarker of germinal center activity</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2016</year>) <volume>113</volume>:<fpage>2702</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1520112113</pub-id><pub-id pub-id-type="pmid">26908875</pub-id><pub-id pub-id-type="pmcid">PMC4790995</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitt</surname><given-names>N</given-names></name><name name-style="western"><surname>Bentebibel</surname><given-names>SE</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>H</given-names></name></person-group>. <article-title>Phenotype and functions of memory Tfh cells in human blood</article-title>. <source>Trends Immunol</source> (<year>2014</year>) <volume>35</volume>:<fpage>436</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2014.06.002</pub-id><pub-id pub-id-type="pmid">24998903</pub-id><pub-id pub-id-type="pmcid">PMC4152409</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>CG</given-names></name><name name-style="western"><surname>Cyster</surname><given-names>JG</given-names></name></person-group>. <article-title>How T cells earn the follicular rite of passage</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>:<fpage>671</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.11.001</pub-id><pub-id pub-id-type="pmid">22118524</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schultz</surname><given-names>BT</given-names></name><name name-style="western"><surname>Teigler</surname><given-names>JE</given-names></name><name name-style="western"><surname>Pissani</surname><given-names>F</given-names></name><name name-style="western"><surname>Oster</surname><given-names>AF</given-names></name><name name-style="western"><surname>Kranias</surname><given-names>G</given-names></name><name name-style="western"><surname>Alter</surname><given-names>G</given-names></name><etal/></person-group><article-title>Circulating HIV-specific interleukin-21(+)CD4(+) T cells represent peripheral Tfh cells with antigen-dependent helper functions</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>:<fpage>167</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.12.011</pub-id><pub-id pub-id-type="pmid">26795249</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vargas-Inchaustegui</surname><given-names>DA</given-names></name><name name-style="western"><surname>Demers</surname><given-names>A</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kang</surname><given-names>G</given-names></name><name name-style="western"><surname>Ball</surname><given-names>D</given-names></name><name name-style="western"><surname>Tuero</surname><given-names>I</given-names></name><etal/></person-group><article-title>Vaccine induction of lymph node-resident simian immunodeficiency virus Env-specific T follicular helper cells in rhesus macaques</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>196</volume>:<fpage>1700</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1502137</pub-id><pub-id pub-id-type="pmid">26773147</pub-id><pub-id pub-id-type="pmcid">PMC4744561</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>SM</given-names></name><name name-style="western"><surname>Carnathan</surname><given-names>DG</given-names></name><name name-style="western"><surname>Wu</surname><given-names>JE</given-names></name><name name-style="western"><surname>Kendric</surname><given-names>K</given-names></name><name name-style="western"><surname>Torrents de la Pe&#241;a</surname><given-names>A</given-names></name><etal/></person-group><article-title>Cytokine-independent detection of antigen-specific germinal center T follicular helper cells in immunized nonhuman primates using a live cell activation-induced marker technique</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>:<fpage>994</fpage>&#8211;<lpage>1002</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1600320</pub-id><pub-id pub-id-type="pmid">27335502</pub-id><pub-id pub-id-type="pmcid">PMC4955744</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>HC</given-names></name><name name-style="western"><surname>Masur</surname><given-names>H</given-names></name><name name-style="western"><surname>Edgar</surname><given-names>LC</given-names></name><name name-style="western"><surname>Whalen</surname><given-names>G</given-names></name><name name-style="western"><surname>Rook</surname><given-names>AH</given-names></name><name name-style="western"><surname>Fauci</surname><given-names>AS</given-names></name></person-group>. <article-title>Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome</article-title>. <source>N Engl J Med</source> (<year>1983</year>) <volume>309</volume>:<fpage>453</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1056/NEJM198308253090803</pub-id><pub-id pub-id-type="pmid">6224088</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnittman</surname><given-names>SM</given-names></name><name name-style="western"><surname>Lane</surname><given-names>HC</given-names></name><name name-style="western"><surname>Higgins</surname><given-names>SE</given-names></name><name name-style="western"><surname>Folks</surname><given-names>T</given-names></name><name name-style="western"><surname>Fauci</surname><given-names>AS</given-names></name></person-group>. <article-title>Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus</article-title>. <source>Science</source> (<year>1986</year>) <volume>233</volume>:<fpage>1084</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1126/science.3016902</pub-id><pub-id pub-id-type="pmid">3016902</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Metroka</surname><given-names>CE</given-names></name><name name-style="western"><surname>Cunningham-Rundles</surname><given-names>S</given-names></name><name name-style="western"><surname>Pollack</surname><given-names>MS</given-names></name><name name-style="western"><surname>Sonnabend</surname><given-names>JA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>B</given-names></name><etal/></person-group><article-title>Generalized lymphadenopathy in homosexual men</article-title>. <source>Ann Intern Med</source> (<year>1983</year>) <volume>99</volume>:<fpage>585</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.7326/0003-4819-99-5-585</pub-id><pub-id pub-id-type="pmid">6605701</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Milito</surname><given-names>A</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>A</given-names></name><name name-style="western"><surname>Titanji</surname><given-names>K</given-names></name><name name-style="western"><surname>Thorstensson</surname><given-names>R</given-names></name><name name-style="western"><surname>Reizenstein</surname><given-names>E</given-names></name><name name-style="western"><surname>Narita</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection</article-title>. <source>Blood</source> (<year>2004</year>) <volume>103</volume>:<fpage>2180</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2003-07-2375</pub-id><pub-id pub-id-type="pmid">14604962</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>M</given-names></name><name name-style="western"><surname>Okitsu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>N</given-names></name><name name-style="western"><surname>McHeyzer-Williams</surname><given-names>L</given-names></name></person-group>. <article-title>Molecular programming of B cell memory</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>12</volume>:<fpage>24</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1038/nri3128</pub-id><pub-id pub-id-type="pmid">22158414</pub-id><pub-id pub-id-type="pmcid">PMC3947622</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fahey</surname><given-names>LM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>EB</given-names></name><name name-style="western"><surname>Elsaesser</surname><given-names>H</given-names></name><name name-style="western"><surname>Fistonich</surname><given-names>CD</given-names></name><name name-style="western"><surname>McGavern</surname><given-names>DB</given-names></name><name name-style="western"><surname>Brooks</surname><given-names>DG</given-names></name></person-group>. <article-title>Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>:<fpage>987</fpage>&#8211;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20101773</pub-id><pub-id pub-id-type="pmid">21536743</pub-id><pub-id pub-id-type="pmcid">PMC3092345</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cubas</surname><given-names>R</given-names></name><name name-style="western"><surname>Perreau</surname><given-names>M</given-names></name></person-group>. <article-title>The dysfunction of T follicular helper cells</article-title>. <source>Curr Opin HIV AIDS</source> (<year>2014</year>) <volume>9</volume>:<fpage>485</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1097/COH.0000000000000095</pub-id><pub-id pub-id-type="pmid">25023620</pub-id><pub-id pub-id-type="pmcid">PMC4176897</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pallikkuth</surname><given-names>S</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>K</given-names></name><name name-style="western"><surname>Villinger</surname><given-names>F</given-names></name><name name-style="western"><surname>Dosterii</surname><given-names>M</given-names></name><name name-style="western"><surname>Vaccari</surname><given-names>M</given-names></name><name name-style="western"><surname>Franchini</surname><given-names>G</given-names></name><etal/></person-group><article-title>Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication</article-title>. <source>Vaccine</source> (<year>2011</year>) <volume>29</volume>:<fpage>9229</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.09.118</pub-id><pub-id pub-id-type="pmid">21996099</pub-id><pub-id pub-id-type="pmcid">PMC3260006</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Velu</surname><given-names>V</given-names></name><name name-style="western"><surname>Mylvaganam</surname><given-names>GH</given-names></name><name name-style="western"><surname>Gangadhara</surname><given-names>S</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>SS</given-names></name><name name-style="western"><surname>Gumber</surname><given-names>S</given-names></name><etal/></person-group><article-title>Induction of Th1-biased T follicular helper (Tfh) cells in lymphoid tissues during chronic simian immunodeficiency virus infection defines functionally distinct germinal center Tfh cells</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>:<fpage>1832</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1600143</pub-id><pub-id pub-id-type="pmid">27481845</pub-id><pub-id pub-id-type="pmcid">PMC4992610</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>RM</given-names></name><name name-style="western"><surname>Gautam</surname><given-names>R</given-names></name><name name-style="western"><surname>Matus-Nicodemos</surname><given-names>R</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>SD</given-names></name><name name-style="western"><surname>Boswell</surname><given-names>KL</given-names></name><etal/></person-group><article-title>Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection</article-title>. <source>Sci Transl Med</source> (<year>2015</year>) <volume>7</volume>:<fpage>298ra120</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.aab3964</pub-id><pub-id pub-id-type="pmid">26223303</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miles</surname><given-names>B</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SM</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kimball</surname><given-names>A</given-names></name><name name-style="western"><surname>Chamanian</surname><given-names>M</given-names></name><name name-style="western"><surname>Meditz</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>8608</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms9608</pub-id><pub-id pub-id-type="pmid">26482032</pub-id><pub-id pub-id-type="pmcid">PMC4616158</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>SM</given-names></name><name name-style="western"><surname>Miles</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>K</given-names></name><name name-style="western"><surname>Folkvord</surname><given-names>J</given-names></name><name name-style="western"><surname>Meditz</surname><given-names>AL</given-names></name><name name-style="western"><surname>McCarter</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Follicular regulatory T cells are highly permissive to R5-tropic HIV-1</article-title>. <source>J Virol</source> (<year>2017</year>) <volume>91</volume>:<fpage>e430</fpage>&#8211;<lpage>417</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00430-17</pub-id><pub-id pub-id-type="pmid">28615202</pub-id><pub-id pub-id-type="pmcid">PMC5553166</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Toccanier</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kapanci</surname><given-names>Y</given-names></name></person-group>. <article-title>Lymphadenopathy in drug addicts. A study of the distribution of T lymphocyte subsets in the lymph nodes</article-title>. <source>Virchows Arch A Pathol Anat Histopathol</source> (<year>1985</year>) <volume>406</volume>:<fpage>149</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1007/BF00737082</pub-id><pub-id pub-id-type="pmid">3923695</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brask</surname><given-names>S</given-names></name><name name-style="western"><surname>Hager</surname><given-names>H</given-names></name><name name-style="western"><surname>Pallesen</surname><given-names>G</given-names></name><name name-style="western"><surname>Porwit</surname><given-names>A</given-names></name><name name-style="western"><surname>Biberfeld</surname><given-names>P</given-names></name><name name-style="western"><surname>Gerstoft</surname><given-names>J</given-names></name></person-group>. <article-title>Quantification of CD8-positive lymphocytes in lymph node follicles from HIV-infected male homosexuals and controls</article-title>. <source>Acta Pathol Microbiol Immunol Scand A</source> (<year>1987</year>) <volume>95</volume>:<fpage>155</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">3113174</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1699-0463.1987.tb00024_95a.x</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zha</surname><given-names>J</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Shi</surname><given-names>P</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name></person-group>. <article-title>CXCR5+CD8+ T cells present elevated capacity in mediating cytotoxicity toward autologous tumor cells through interleukin 10 in diffuse large B-cell lymphoma</article-title>. <source>Int Immunopharmacol</source> (<year>2017</year>) <volume>50</volume>:<fpage>146</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.intimp.2017.06.020</pub-id><pub-id pub-id-type="pmid">28662433</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>R</given-names></name><name name-style="western"><surname>Hou</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Q</given-names></name><name name-style="western"><surname>Han</surname><given-names>M</given-names></name><etal/></person-group><article-title>Follicular CXCR5-expressing CD8(+) T cells curtail chronic viral infection</article-title>. <source>Nature</source> (<year>2016</year>) <volume>537</volume>:<fpage>412</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1038/nature19317</pub-id><pub-id pub-id-type="pmid">27501245</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mylvaganam</surname><given-names>GH</given-names></name><name name-style="western"><surname>Velu</surname><given-names>V</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Sadagopal</surname><given-names>S</given-names></name><name name-style="western"><surname>Kwa</surname><given-names>S</given-names></name><name name-style="western"><surname>Basu</surname><given-names>R</given-names></name><etal/></person-group><article-title>Diminished viral control during simian immunodeficiency virus infection is associated with aberrant PD-1hi CD4 T cell enrichment in the lymphoid follicles of the rectal mucosa</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>:<fpage>4527</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401222</pub-id><pub-id pub-id-type="pmid">25246494</pub-id><pub-id pub-id-type="pmcid">PMC4201952</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tenner-Racz</surname><given-names>K</given-names></name><name name-style="western"><surname>Racz</surname><given-names>P</given-names></name><name name-style="western"><surname>Bofill</surname><given-names>M</given-names></name><name name-style="western"><surname>Schulz-Meyer</surname><given-names>A</given-names></name><name name-style="western"><surname>Dietrich</surname><given-names>M</given-names></name><name name-style="western"><surname>Kern</surname><given-names>P</given-names></name><etal/></person-group><article-title>HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS</article-title>. <source>Am J Pathol</source> (<year>1986</year>) <volume>123</volume>:<fpage>9</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="pmid">3008562</pub-id><pub-id pub-id-type="pmcid">PMC1888153</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biberfeld</surname><given-names>P</given-names></name><name name-style="western"><surname>Ost</surname><given-names>A</given-names></name><name name-style="western"><surname>Porwit</surname><given-names>A</given-names></name><name name-style="western"><surname>Sandstedt</surname><given-names>B</given-names></name><name name-style="western"><surname>Pallesen</surname><given-names>G</given-names></name><name name-style="western"><surname>B&#246;ttiger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS</article-title>. <source>Acta Pathol Microbiol Immunol Scand A</source> (<year>1987</year>) <volume>95</volume>:<fpage>47</fpage>&#8211;<lpage>65</lpage>.<pub-id pub-id-type="pmid">2435107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1699-0463.1987.tb00009_95a.x</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fox</surname><given-names>CH</given-names></name><name name-style="western"><surname>Tenner-R&#225;cz</surname><given-names>K</given-names></name><name name-style="western"><surname>R&#225;cz</surname><given-names>P</given-names></name><name name-style="western"><surname>Firpo</surname><given-names>A</given-names></name><name name-style="western"><surname>Pizzo</surname><given-names>PA</given-names></name><name name-style="western"><surname>Fauci</surname><given-names>AS</given-names></name></person-group>. <article-title>Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA</article-title>. <source>J Infect Dis</source> (<year>1991</year>) <volume>164</volume>:<fpage>1051</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/164.6.1051</pub-id><pub-id pub-id-type="pmid">1955708</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pantaleo</surname><given-names>G</given-names></name><name name-style="western"><surname>Graziosi</surname><given-names>C</given-names></name><name name-style="western"><surname>Demarest</surname><given-names>JF</given-names></name><name name-style="western"><surname>Butini</surname><given-names>L</given-names></name><name name-style="western"><surname>Montroni</surname><given-names>M</given-names></name><name name-style="western"><surname>Fox</surname><given-names>CH</given-names></name><etal/></person-group><article-title>HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease</article-title>. <source>Nature</source> (<year>1993</year>) <volume>362</volume>:<fpage>355</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/362355a0</pub-id><pub-id pub-id-type="pmid">8455722</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piatak</surname><given-names>M</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Saag</surname><given-names>MS</given-names></name><name name-style="western"><surname>Yang</surname><given-names>LC</given-names></name><name name-style="western"><surname>Clark</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Kappes</surname><given-names>JC</given-names></name><name name-style="western"><surname>Luk</surname><given-names>KC</given-names></name><etal/></person-group><article-title>High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR</article-title>. <source>Science</source> (<year>1993</year>) <volume>259</volume>:<fpage>1749</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1126/science.8096089</pub-id><pub-id pub-id-type="pmid">8096089</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graziosi</surname><given-names>C</given-names></name><name name-style="western"><surname>Pantaleo</surname><given-names>G</given-names></name><name name-style="western"><surname>Demarest</surname><given-names>JF</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>OJ</given-names></name><name name-style="western"><surname>Vaccarezza</surname><given-names>M</given-names></name><name name-style="western"><surname>Butini</surname><given-names>L</given-names></name><etal/></person-group><article-title>HIV-1 infection in the lymphoid organs</article-title>. <source>AIDS</source> (<year>1993</year>) <volume>7</volume>(<issue>Suppl 2</issue>):<fpage>S53</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1097/00002030-199311002-00012</pub-id><pub-id pub-id-type="pmid">8161447</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veazey</surname><given-names>RS</given-names></name><name name-style="western"><surname>DeMaria</surname><given-names>M</given-names></name><name name-style="western"><surname>Chalifoux</surname><given-names>LV</given-names></name><name name-style="western"><surname>Shvetz</surname><given-names>DE</given-names></name><name name-style="western"><surname>Pauley</surname><given-names>DR</given-names></name><name name-style="western"><surname>Knight</surname><given-names>HL</given-names></name><etal/></person-group><article-title>Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection</article-title>. <source>Science</source> (<year>1998</year>) <volume>280</volume>:<fpage>427</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1126/science.280.5362.427</pub-id><pub-id pub-id-type="pmid">9545219</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenchley</surname><given-names>JM</given-names></name><name name-style="western"><surname>Vinton</surname><given-names>C</given-names></name><name name-style="western"><surname>Tabb</surname><given-names>B</given-names></name><name name-style="western"><surname>Hao</surname><given-names>XP</given-names></name><name name-style="western"><surname>Connick</surname><given-names>E</given-names></name><name name-style="western"><surname>Paiardini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections</article-title>. <source>Blood</source> (<year>2012</year>) <volume>120</volume>:<fpage>4172</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-06-437608</pub-id><pub-id pub-id-type="pmid">22990012</pub-id><pub-id pub-id-type="pmcid">PMC3501715</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maldarelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>S</given-names></name><name name-style="western"><surname>King</surname><given-names>MS</given-names></name><name name-style="western"><surname>Wiegand</surname><given-names>A</given-names></name><name name-style="western"><surname>Polis</surname><given-names>MA</given-names></name><name name-style="western"><surname>Mican</surname><given-names>J</given-names></name><etal/></person-group><article-title>ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia</article-title>. <source>PLoS Pathog</source> (<year>2007</year>) <volume>3</volume>:<fpage>e46</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.0030046</pub-id><pub-id pub-id-type="pmid">17411338</pub-id><pub-id pub-id-type="pmcid">PMC1847689</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Phetsouphanh</surname><given-names>C</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>K</given-names></name><name name-style="western"><surname>Aggrawal</surname><given-names>A</given-names></name><name name-style="western"><surname>Graff-Dubois</surname><given-names>S</given-names></name><name name-style="western"><surname>Roche</surname><given-names>M</given-names></name><etal/></person-group><article-title>HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>376</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00376</pub-id><pub-id pub-id-type="pmid">28484447</pub-id><pub-id pub-id-type="pmcid">PMC5399036</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruffin</surname><given-names>N</given-names></name><name name-style="western"><surname>Brezar</surname><given-names>V</given-names></name><name name-style="western"><surname>Ayinde</surname><given-names>D</given-names></name><name name-style="western"><surname>Lefebvre</surname><given-names>C</given-names></name><name name-style="western"><surname>Schulze Zur Wiesch</surname><given-names>J</given-names></name><name name-style="western"><surname>van Lunzen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1</article-title>. <source>AIDS</source> (<year>2015</year>) <volume>29</volume>:<fpage>519</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1097/QAD.0000000000000594</pub-id><pub-id pub-id-type="pmid">25715102</pub-id><pub-id pub-id-type="pmcid">PMC4342413</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Laguette</surname><given-names>N</given-names></name><name name-style="western"><surname>Sobhian</surname><given-names>B</given-names></name><name name-style="western"><surname>Casartelli</surname><given-names>N</given-names></name><name name-style="western"><surname>Ringeard</surname><given-names>M</given-names></name><name name-style="western"><surname>Chable-Bessia</surname><given-names>C</given-names></name><name name-style="western"><surname>S&#233;g&#233;ral</surname><given-names>E</given-names></name><etal/></person-group><article-title>SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx</article-title>. <source>Nature</source> (<year>2011</year>) <volume>474</volume>:<fpage>654</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature10117</pub-id><pub-id pub-id-type="pmid">21613998</pub-id><pub-id pub-id-type="pmcid">PMC3595993</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandel</surname><given-names>TE</given-names></name><name name-style="western"><surname>Phipps</surname><given-names>RP</given-names></name><name name-style="western"><surname>Abbot</surname><given-names>AP</given-names></name><name name-style="western"><surname>Tew</surname><given-names>JG</given-names></name></person-group>. <article-title>Long-term antigen retention by dendritic cells in the popliteal lymph node of immunized mice</article-title>. <source>Immunology</source> (<year>1981</year>) <volume>43</volume>:<fpage>353</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="pmid">7251058</pub-id><pub-id pub-id-type="pmcid">PMC1555024</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aguzzi</surname><given-names>A</given-names></name><name name-style="western"><surname>Kranich</surname><given-names>J</given-names></name><name name-style="western"><surname>Krautler</surname><given-names>NJ</given-names></name></person-group>. <article-title>Follicular dendritic cells: origin, phenotype, and function in health and disease</article-title>. <source>Trends Immunol</source> (<year>2014</year>) <volume>35</volume>:<fpage>105</fpage>&#8211;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2013.11.001</pub-id><pub-id pub-id-type="pmid">24315719</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spiegel</surname><given-names>H</given-names></name><name name-style="western"><surname>Herbst</surname><given-names>H</given-names></name><name name-style="western"><surname>Niedobitek</surname><given-names>G</given-names></name><name name-style="western"><surname>Foss</surname><given-names>HD</given-names></name><name name-style="western"><surname>Stein</surname><given-names>H</given-names></name></person-group>. <article-title>Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells</article-title>. <source>Am J Pathol</source> (<year>1992</year>) <volume>140</volume>:<fpage>15</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">1530997</pub-id><pub-id pub-id-type="pmcid">PMC1886262</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heath</surname><given-names>SL</given-names></name><name name-style="western"><surname>Tew</surname><given-names>JG</given-names></name><name name-style="western"><surname>Tew</surname><given-names>JG</given-names></name><name name-style="western"><surname>Szakal</surname><given-names>AK</given-names></name><name name-style="western"><surname>Burton</surname><given-names>GF</given-names></name></person-group>. <article-title>Follicular dendritic cells and human immunodeficiency virus infectivity</article-title>. <source>Nature</source> (<year>1995</year>) <volume>377</volume>(<issue>6551</issue>):<fpage>740</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/377740a0</pub-id><pub-id pub-id-type="pmid">7477265</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keele</surname><given-names>BF</given-names></name><name name-style="western"><surname>Tazi</surname><given-names>L</given-names></name><name name-style="western"><surname>Gartner</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Burgon</surname><given-names>TB</given-names></name><name name-style="western"><surname>Estes</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1</article-title>. <source>J Virol</source> (<year>2008</year>) <volume>82</volume>:<fpage>5548</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00124-08</pub-id><pub-id pub-id-type="pmid">18385252</pub-id><pub-id pub-id-type="pmcid">PMC2395176</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ayala</surname><given-names>VI</given-names></name><name name-style="western"><surname>Deleage</surname><given-names>C</given-names></name><name name-style="western"><surname>Trivett</surname><given-names>MT</given-names></name><name name-style="western"><surname>Jain</surname><given-names>S</given-names></name><name name-style="western"><surname>Coren</surname><given-names>LV</given-names></name><name name-style="western"><surname>Breed</surname><given-names>MW</given-names></name><etal/></person-group><article-title>CXCR5-dependent entry of CD8 T cells into rhesus macaque B-cell follicles achieved through T-cell engineering</article-title>. <source>J Virol</source> (<year>2017</year>) <volume>91</volume>:<fpage>e2507</fpage>&#8211;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02507-16</pub-id><pub-id pub-id-type="pmid">28298605</pub-id><pub-id pub-id-type="pmcid">PMC5432868</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tomaras</surname><given-names>GD</given-names></name><name name-style="western"><surname>Yates</surname><given-names>NL</given-names></name><name name-style="western"><surname>Liu</surname><given-names>P</given-names></name><name name-style="western"><surname>Qin</surname><given-names>L</given-names></name><name name-style="western"><surname>Fouda</surname><given-names>GG</given-names></name><name name-style="western"><surname>Chavez</surname><given-names>LL</given-names></name><etal/></person-group><article-title>Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia</article-title>. <source>J Virol</source> (<year>2008</year>) <volume>82</volume>:<fpage>12449</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01708-08</pub-id><pub-id pub-id-type="pmid">18842730</pub-id><pub-id pub-id-type="pmcid">PMC2593361</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>ES</given-names></name><name name-style="western"><surname>Madiga</surname><given-names>MC</given-names></name><name name-style="western"><surname>Hermanus</surname><given-names>T</given-names></name><name name-style="western"><surname>Moore</surname><given-names>PL</given-names></name><name name-style="western"><surname>Wibmer</surname><given-names>CK</given-names></name><name name-style="western"><surname>Tumba</surname><given-names>NL</given-names></name><etal/></person-group><article-title>The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection</article-title>. <source>J Virol</source> (<year>2011</year>) <volume>85</volume>:<fpage>4828</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00198-11</pub-id><pub-id pub-id-type="pmid">21389135</pub-id><pub-id pub-id-type="pmcid">PMC3126191</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhillon</surname><given-names>AK</given-names></name><name name-style="western"><surname>Donners</surname><given-names>H</given-names></name><name name-style="western"><surname>Pantophlet</surname><given-names>R</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>WE</given-names></name><name name-style="western"><surname>Decker</surname><given-names>JM</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>GM</given-names></name><etal/></person-group><article-title>Dissecting the neutralizing antibody specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors</article-title>. <source>J Virol</source> (<year>2007</year>) <volume>81</volume>:<fpage>6548</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02749-06</pub-id><pub-id pub-id-type="pmid">17409160</pub-id><pub-id pub-id-type="pmcid">PMC1900098</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mascola</surname><given-names>JR</given-names></name><name name-style="western"><surname>Stiegler</surname><given-names>G</given-names></name><name name-style="western"><surname>VanCott</surname><given-names>TC</given-names></name><name name-style="western"><surname>Katinger</surname><given-names>H</given-names></name><name name-style="western"><surname>Carpenter</surname><given-names>CB</given-names></name><name name-style="western"><surname>Hanson</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies</article-title>. <source>Nat Med</source> (<year>2000</year>) <volume>6</volume>:<fpage>207</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1038/72318</pub-id><pub-id pub-id-type="pmid">10655111</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibata</surname><given-names>R</given-names></name><name name-style="western"><surname>Igarashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Haigwood</surname><given-names>N</given-names></name><name name-style="western"><surname>Buckler-White</surname><given-names>A</given-names></name><name name-style="western"><surname>Ogert</surname><given-names>R</given-names></name><name name-style="western"><surname>Ross</surname><given-names>W</given-names></name><etal/></person-group><article-title>Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys</article-title>. <source>Nat Med</source> (<year>1999</year>) <volume>5</volume>:<fpage>204</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1038/5568</pub-id><pub-id pub-id-type="pmid">9930869</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burton</surname><given-names>DR</given-names></name><name name-style="western"><surname>Hangartner</surname><given-names>L</given-names></name></person-group>. <article-title>Broadly neutralizing antibodies to HIV and their role in vaccine design</article-title>. <source>Annu Rev Immunol</source> (<year>2016</year>) <volume>34</volume>:<fpage>635</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055515</pub-id><pub-id pub-id-type="pmid">27168247</pub-id><pub-id pub-id-type="pmcid">PMC6034635</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheid</surname><given-names>JF</given-names></name><name name-style="western"><surname>Mouquet</surname><given-names>H</given-names></name><name name-style="western"><surname>Feldhahn</surname><given-names>N</given-names></name><name name-style="western"><surname>Seaman</surname><given-names>MS</given-names></name><name name-style="western"><surname>Velinzon</surname><given-names>K</given-names></name><name name-style="western"><surname>Pietzsch</surname><given-names>J</given-names></name><etal/></person-group><article-title>Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals</article-title>. <source>Nature</source> (<year>2009</year>) <volume>458</volume>:<fpage>636</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/nature07930</pub-id><pub-id pub-id-type="pmid">19287373</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dimitrov</surname><given-names>DS</given-names></name></person-group>. <article-title>Maturation pathways of cross-reactive HIV-1 neutralizing antibodies</article-title>. <source>Viruses</source> (<year>2009</year>) <volume>1</volume>:<fpage>802</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.3390/v1030802</pub-id><pub-id pub-id-type="pmid">21994570</pub-id><pub-id pub-id-type="pmcid">PMC3185542</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klein</surname><given-names>F</given-names></name><name name-style="western"><surname>Diskin</surname><given-names>R</given-names></name><name name-style="western"><surname>Scheid</surname><given-names>JF</given-names></name><name name-style="western"><surname>Gaebler</surname><given-names>C</given-names></name><name name-style="western"><surname>Mouquet</surname><given-names>H</given-names></name><name name-style="western"><surname>Georgiev</surname><given-names>IS</given-names></name><etal/></person-group><article-title>Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization</article-title>. <source>Cell</source> (<year>2013</year>) <volume>153</volume>:<fpage>126</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2013.03.018</pub-id><pub-id pub-id-type="pmid">23540694</pub-id><pub-id pub-id-type="pmcid">PMC3792590</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simek</surname><given-names>MD</given-names></name><name name-style="western"><surname>Rida</surname><given-names>W</given-names></name><name name-style="western"><surname>Priddy</surname><given-names>FH</given-names></name><name name-style="western"><surname>Pung</surname><given-names>P</given-names></name><name name-style="western"><surname>Carrow</surname><given-names>E</given-names></name><name name-style="western"><surname>Laufer</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm</article-title>. <source>J Virol</source> (<year>2009</year>) <volume>83</volume>:<fpage>7337</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00110-09</pub-id><pub-id pub-id-type="pmid">19439467</pub-id><pub-id pub-id-type="pmcid">PMC2704778</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francica</surname><given-names>JR</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shingai</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramesh</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>6565</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms7565</pub-id><pub-id pub-id-type="pmid">25858157</pub-id><pub-id pub-id-type="pmcid">PMC4403371</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kasturi</surname><given-names>SP</given-names></name><name name-style="western"><surname>Kozlowskib</surname><given-names>PA</given-names></name><name name-style="western"><surname>Nakayaa</surname><given-names>HI</given-names></name><name name-style="western"><surname>Burgerc</surname><given-names>MC</given-names></name><name name-style="western"><surname>Russoc</surname><given-names>P</given-names></name><name name-style="western"><surname>Phama</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in TRIM5alpha restrictive macaques</article-title>. <source>J Virol</source> (<year>2017</year>) <volume>91</volume>:<fpage>e1844</fpage>&#8211;<lpage>1816</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01844-16</pub-id><pub-id pub-id-type="pmcid">PMC5286877</pub-id><pub-id pub-id-type="pmid">27928002</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Havenar-Daughton</surname><given-names>C</given-names></name><name name-style="western"><surname>Carnathan</surname><given-names>DG</given-names></name><name name-style="western"><surname>Torrents de la Pe&#241;a</surname><given-names>A</given-names></name><name name-style="western"><surname>Pauthner</surname><given-names>M</given-names></name><name name-style="western"><surname>Briney</surname><given-names>B</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Direct probing of germinal center responses reveals immunological features and bottlenecks for neutralizing antibody responses to HIV Env trimer</article-title>. <source>Cell Rep</source> (<year>2016</year>) <volume>17</volume>:<fpage>2195</fpage>&#8211;<lpage>209</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.085</pub-id><pub-id pub-id-type="pmid">27880897</pub-id><pub-id pub-id-type="pmcid">PMC5142765</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haynes</surname><given-names>BF</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>PB</given-names></name><name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Zolla-Pazner</surname><given-names>S</given-names></name><name name-style="western"><surname>Tomaras</surname><given-names>GD</given-names></name><name name-style="western"><surname>Alam</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Immune-correlates analysis of an HIV-1 vaccine efficacy trial</article-title>. <source>N Engl J Med</source> (<year>2012</year>) <volume>366</volume>:<fpage>1275</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa1113425</pub-id><pub-id pub-id-type="pmid">22475592</pub-id><pub-id pub-id-type="pmcid">PMC3371689</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaccari</surname><given-names>M</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>SN</given-names></name><name name-style="western"><surname>Fourati</surname><given-names>S</given-names></name><name name-style="western"><surname>Schifanella</surname><given-names>L</given-names></name><name name-style="western"><surname>Liyanage</surname><given-names>NP</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>M</given-names></name><etal/></person-group><article-title>Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition</article-title>. <source>Nat Med</source> (<year>2016</year>) <volume>22</volume>:<fpage>762</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4105</pub-id><pub-id pub-id-type="pmid">27239761</pub-id><pub-id pub-id-type="pmcid">PMC5916782</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iyer</surname><given-names>SS</given-names></name><name name-style="western"><surname>Gangadhara</surname><given-names>S</given-names></name><name name-style="western"><surname>Victor</surname><given-names>B</given-names></name><name name-style="western"><surname>Gomez</surname><given-names>R</given-names></name><name name-style="western"><surname>Basu</surname><given-names>R</given-names></name><name name-style="western"><surname>Hong</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Codelivery of envelope protein in alum with MVA vaccine induces CXCR3-biased CXCR5+ and CXCR5- CD4 T cell responses in rhesus macaques</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>195</volume>:<fpage>994</fpage>&#8211;<lpage>1005</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1500083</pub-id><pub-id pub-id-type="pmid">26116502</pub-id><pub-id pub-id-type="pmcid">PMC4506863</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>